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1. Natural products as pharmaceutical source 
Natural products have been used since ancient times as a pharmacological 
source. Medicinal plant therapy has been based on empirical findings for 
thousands of years, leading to the birth of several traditional systems of 
medicine (e.g. Chinese Traditional Medicine, European Medicine, American 
Traditional Medicine, etc.). However, since from the end of XVIII century, the 
concept of finding the single active principle of plants began to have an 
important role in drug discovery. Moreover, the Industrial Revolution and the 
development of organic chemistry moved the attention to synthetic 
compounds in pharmacological therapies. However, there has recently been 
a shift in the research from the single active principle to a multidrug treatment, 
which is on-going. The reason could be found in the increased inefficacy and 
side effects shown by monodrug therapies. These complications have been 
mainly observed in chronic disease treatments such as antiinflammatory and 
anticarcenogenic drugs [2]. The inefficacy could also be related to different 
targets involved in these kinds of diseases. In light of all these considerations, 
a mixture of several active molecules (Par. 1 - Appendix), such as those 
present in natural products, could lead to more therapeutic effects and 
improve the health status of patients. These results can be obtained by the 
synergy of plant extract components. Wagner H. and Ulrich-Merzenich G. [1] 
described different mechanisms of synergy effects : the “synergistic multi-
target effects” (Figure 1) which means that the single constituents of the 
extract affect several targets, thus cooperating in an agonistic way ; 
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“Pharmacokinetic effects based on improved solubility, resorption rate and 
enhanced bioavailability” which indicates that some extract components, even 
if they themselves don’t possess an activity, can act as enhancer of the 
bioavailability of the other compounds ; the inhibition of bacteria resistance 
through antibiotics ; and  the respective elimination or neutralization of side 
effects by compounds contained in the extract. 
 
 
 
 
 
 
 
Figure 1 – Synergistic multi-target effects graphic description [1] 
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2. Importance of phytomedicines mechanisms of action and ADME 
profiles elucidation 
There are new forms of registered plant-derived medicines (phytomedicines) 
that are not single chemical entities but a complex mixture of active and inert 
ingredients derived form a crude extraction. However the development of 
these kinds of products have long been limited since adequate methods to 
standardize complex plant mixtures as well as to rationalize complex modes 
of actions were lacking. 
The standardization of phytomedicine is important to guarantee a specific 
concentration range of the bioactive components [3]. Since plant composition 
is influenced by different factors, such as origin, growth, storage and 
processing conditions, standardization processes should include all these 
steps [3]. In this way, a higher level of quality, safety and efficacy of plant 
based products can be achieved. 
Moreover, ADMET studies were limited due to the complexity of the 
phytomedicines. Hence, most of the information that is usually retrieved for 
NCE during the drug discovery stage, such as the ADME profile and the 
mechanism of action, was often not obtained for such complex natural 
derivatives, limiting their efficacy and application in therapy. Although many 
answers have now been provided on some bioactive components of plants 
(Par. 2 - Appendix), this issue is still far from established. 
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In fact only recently, thanks to the advent of novel MS techniques and to the 
commercial availability of high resolution MS analyzers, the opportunity to 
determine the ADME profiles of plant extracts and to explore their mode of 
action has become possible [4]. Advanced analytical techniques play an 
increasingly important role in the characterization, identification and 
quantification of plant extract compounds, not only in the context of their 
natural source but also in biological fluids to study their bioavailability and to 
discover the active compounds (Par 3 – Appendix). Mass spectrometry has 
become one of the main standard techniques in this field because of the high 
sensitivity and specificity of the available mass analyzers. 
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The aim of the present work has been to set-up and apply state of the art MS 
strategies to better understand the bioavailability, bioatcivity and mechanisms 
of action of some plant extracts.  
In the first part, attention was focused on the set-up and application of MS 
methods to elucidate biological activities and mechanisms of action of plant 
extracts and in particular on two studies regarding: 
 The elucidation of the ability of different rice extracts to inhibit protein 
carbonylation by reactive carbonyl species. Based on the knowledge 
that rice extracts have antioxidant properties, the screening of different 
types of rice extract was performed to select the most active. A strategy 
based on a isotopic labelling of the reactive carbonyl species was set up 
to get a specific mass pattern of the bioactive components present in the 
most active rice extract selected. 
 
 The evaluation of tannin capacity to precipitate bradykinin, a proline rich 
peptide involved in the inflammatory cascade. Tannins are widely 
distributed in plant extracts and their interaction with proline rich proline 
has long been studied, but the extent of the protein precipitation was only 
quantified by low precision methods. The ESI-MS method developed 
and the fast sample preparation aimed at obtaining suitable, accurate 
and easily comparable results. 
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Considering that ADME profile of plant extracts is a quite challenging 
approach, in the second part of this thesis I applied MS strategies based on 
targeted and untageted analyses to overcome these limits. In particular I 
studied the ADME profile of two standardized berry extracts in humans and 
rodents: 
 Since there are controversial hypotheses as to the identity of the 
bioactive components of cranberry used in the prevention of urinary tract 
infections, the purpose was to set up a HRMS method able to detect 
known and unknown metabolites in urine. An on target and an off target 
data analysis methods were used to identify cranberry (Vaccinium 
macrocarpon) components and metabolites in human urine after the 
assumption of a standardized cranberry extract (Anthocran™) for 7 
days. The dosage used was the same as found to be active in human 
studies in order to replicate real life conditions. Urine fractions were also 
tested on C. albicans adhesion in order to obtain the active fractions and 
thus a list of possible bioactive components. 
 
 Anthocyanin bioavailability is known to be low, but less is known about 
the mechanism of absorption. In the present work the research was 
focused on the evaluation of the role of GLUT transporters (GLUT2 and 
sGLT1) in anthocyanins absorption. A quantitative HPLC-MS/MS 
method was set up to determine the absorption of 15 anthocyanins 
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present in a standardized bilberry extract (Mirtoselect®, 36% 
anthocyanins) in rats. The investigation was performed under fasted and 
fed conditions and, in fasting conditions with the co-somministration of 
glucose. The pharmacokinetic results were associated with docking 
studies on the two transporters to obtain the final evidence of GLUT 
transporters involvement. 
 
  
 
 
 
 
 
 
 
Set-up and application of MS methods to 
elucidate biological activities and 
mechanisms of action of plant extracts
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Set-up of an isotopic labelling procedure for the 
characterization of HNE-sequestering agents in natural 
extracts and its application for the identification of 
anthocyanidins in black rice giant germ 
 
 
 
 
 
 
 
 
 
 
 
 
 
III – Study 1 
19 
 
Abstract 
 
Reactive carbonyl species (RCS) are cytotoxic molecules originating from lipid 
peroxidation and sugar oxidation. Due to their involvement in the onset and 
propagation of different oxidative based diseases, RCS are not only 
considered as biomarkers of oxidative stress, but also as promising drug 
targets. Natural derivatives represent a very interesting source of potential 
RCS scavenging molecules but their investigation is limited, mainly by the lack 
of analytical methods able to screen and identify the bioactive compounds 
contained in complex matrices. 
In the present work, we test the ability of water-soluble rice extracts to act as 
inhibitors of RCS-induced protein carbonylation. The method was based on 
ubiquitin as protein model and HNE as RCS. Black rice with giant germ extract 
was found to be the most active. Identification of bioactive compounds was 
then carried out by an isotopic signature profile method using the 
characteristic isotopic ion cluster generated by the mixture of HNE:2H5-HNE 
mixed at a 1:1 stoichiometric ratio. Available databases were used to obtain 
the structures of the possible bioactive components. The identified 
compounds were tested as HNE sequestering agent by using a HPLC-UV 
analysis. 
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1. Introduction 
Reactive carbonyl species (RCS) are a class of breakdown products arising 
from the oxidation of sugars and lipids which can be formed either 
exogenously, for instance during food processing or cooking, and 
endogenously, in different physio-pathological conditions. RCS are chemically 
quite heterogeneous, belonging to different classes, including di-aldehydes, 
cheto-aldehydes and alfa,beta-unsaturated aldehydes. RCS have the 
common property of covalently reacting with nucleophilic substrates such as 
proteins, leading to the formation of covalent adducts which are named ALEs, 
when RCS originate from lipids, and AGEs when the precursors are from 
sugars [1]. Since the 1980s, RCS and the corresponding reaction products 
have been widely used as markers of oxidative stress and several analytical 
methods for their measurements have been set-up and widely applied. More 
recently, due to growing literature reporting the involvement of AGEs and 
ALEs in the onset and propagation of some human diseases, RCS have been 
considered not only as biomarkers but also as potential drug targets [2, 3]. 
Among the damaging RCS, HNE is one of the most studied since its discovery 
by Hermann Esterbauer in 1964 and this due to its abundance, reactivity, and 
biological effects.  The strict link between HNE tissue/blood levels and some 
human diseases suggested the HNE involvement in this kind of diseases. 
Several studies based on cell signalling and protein covalent modification 
have since reported the molecular mechanisms involved in the cytotoxic effect 
of HNE [4]. 
III – Study 1 
21 
 
Different molecular approaches for reducing the overproduction of HNE and 
in general of RCS have been reported and summarized in some recent 
reviews. Among the proposed approaches, the most promising is based on 
small nucleophilic molecules (RCS sequestering agents) which covalently 
react with RCS, forming unreactive adducts which are then metabolized and 
excreted. Several RCS sequestering agents have been proposed such as 
aminoguanidine, pyridoxamine, hydralazine and carnosine and their 
protective effects in animal models, as confirmed by several independent labs, 
further underline the promising therapeutic efficacy of targeting HNE [5]. 
Carnosine has recently been reported as the most efficient and selective 
sequestering agent of HNE and its promising activity has been demonstrated 
in animal models and most recently in obese subjects [6]. However, the 
application of carnosine as HNE sequestering agent in humans is limited 
because of its poor bioavailability, due to the presence of serum carnosinases 
which catalyze the hydrolytic cleavage of the dipeptide. Nowadays there is 
great interest in the discovery of novel HNE sequestering agents such as 
carnosine derivatives resistant to carnosinases. 
Among others, an interesting discovery approach to identify novel HNE 
sequestering agents is that based on searching for bioactive compounds in 
plant extracts. Plants are also subject to RCS stress, in particular mediated by 
alfa,beta-unsaturated aldehydes, HNE being the most abundant and toxic 
carbonyl compound formed in stress conditions. Because plants are subject 
to RCS and protein carbonylation damage [7], they have developed efficient 
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enzymatic and non-enzymatic detoxification pathways. Hence, besides 
detoxifying enzymes, it is reasonable to consider the presence of secondary 
metabolites acting as RCS sequestering agents.  Such a hypothesis has been 
partially confirmed by previous studies which have reported that EGCG and 
other polyphenols are effective as sequestering agents of HNE [8] and of other 
RCS, including acrolein and MGO. These results prompted scientists to 
screen the sequestering activity of different plant metabolites and in particular 
polyphenol class. As an example, Zhu et al compared 21 natural polyphenols 
with diverse structural characteristics for their ACR-/HNE-trapping capacities 
under simulated physiological conditions [9].  
To our knowledge, the search for a potential RCS natural sequestering agent 
has been carried out by using isolated molecules or highly purified extracts 
and not applying off-target methods involving crude extracts. One reason is 
the lack of analytical methods able to test the sequestering activity of complex 
matrices and to fish out the bioactive compounds. As an example, one of the 
most used methods to evaluate HNE sequestering efficacy is based on a 
HPLC-UV method for measuring the residual amount of HNE. Such an 
approach is clearly suitable for testing single molecules and not mixtures, 
which would interfere with HNE analysis. 
We recently reported an in vitro high resolution mass spectrometry (MS) 
method to test the ability of compounds, mixtures and extracts to trap RCS by 
measuring their efficacy in inhibiting ubiquitin carbonylation induced by 
reactive carbonyl species including HNE [10]. Such a method was found 
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suitable to evaluate the overall quenching activity of extracts but it does not 
permit the identification of the active components.  
In the present paper, we report an LC-ESI-MS method based on an isotopic 
labelling procedure, which permits the identification of the HNE sequestering 
agents contained in a crude mixture. Together with the ubiquitin method, it 
was applied to search for HNE sequestering agents contained in rice extracts 
prepared from different varieties.  
 
 
2. Materials and Methods 
2.1 Chemicals 
Formic acid (HCOOH), sodium dihydrogen phosphate (NaH2PO4 · H2O), 
sodium hydrogen phosphate (Na2HPO4 · 2.H2O), phenylalanine, gamma-
aminobutyric acid, histidine, lyophilized ubiquitin from bovine erythrocytes 
(BioUltra, ≥98%) and LC–MS grade solvents were purchased from Sigma–
Aldrich (Milan, Italy). Peonidin-glucoside, malvidin, peonidin, pelargonidin and 
tricin-glucoside were from Extrasynthese (Genay, France).  Carnosine (beta-
alanyl-L-histidine) was a generous gift from Flamma S.p.A (Chignolo d’Isola, 
Bergamo, Italy).  LC-grade H2O (18 MΩ cm) was prepared with a Milli-Q H2O 
purification system (Millipore, Bedford, MA, USA). All other reagents were of 
analytical grade. 4-Hydroxy-2-nonenal diethylacetal (HNE-DEA) and 2H5-4-
Hydroxy-2-nonenal diethylacetal (2H5-HNE-DEA) were synthesized according 
to the literature [11] and stored at −20 °C. For each experiment, fresh 4-
hydroxy-2-nonenal (HNE) was prepared starting from stored HNE-DEA, which 
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was evaporated under nitrogen stream and hydrolyzed with 1 mM HCl, pH 3 
for 1 h at room temperature to obtain HNE. The concentration of HNE was 
estimated by measuring the absorbance at λ = 224 nm (molar extinction 
coefficient = 13,750 M−1 × cm−1). 
 
2.2 Plant material 
Rice (Oryza sativa L.) seeds were stored at 4 °C in a cold room before their 
use. Rice extract preparation: the seeds were manually dehulled with a 
wooden rice dehuller and ground to a powder by using a mortar and pestle. 
The milled rice powders were stored at −80 °C until further use. Rice powders 
were extracted in water by using a thermomixer (Eppendorf AG, Germany) at 
700 rpm for 30 min at 37 °C. After centrifugation, the water extract was 
collected into a new tube and then dried in a speed vacuum concentrator. Rice 
extract filtration: for the ubiquitin assay as well as for the isotopic labelling 
procedure, rice powder extract were the dissolved in water and ultrafiltered by 
using a 3 kDa ultrafilters so to remove proteins and high MW components. 
The yield of the low molecular fraction after 3 kDa ultrafiltration was ≈ 10% of 
the starting sample for all the rice varieties tested. 
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2.3 Ubiquitin carbonylation assay 
The effect of rice extracts on HNE-induced protein carbonylation was tested 
by using the ubiquitin assay as previously reported. Briefly, ubiquitin (10 M 
final concentration) chosen as protein target of HNE induced protein 
adduction, was incubated for 24 h at 37°C in 10 mM phosphate buffer in the 
presence of 500 M HNE, together with the rice extracts at increasing 
concentrations (10, 25 and 50 mg/mL).  To remove high molecular 
components which could interfere with the assay, the rice extracts were 
filtered by using Amicon YM3 filters (Millipore, Milan, Italy) and the filtered 
fractions were then used for the assay.  After an incubation time of 24 hours, 
the reactions were stopped by centrifugation using Amicon YM3 filters and the 
extent of ubiquitin carbonylation was determined by MS intact protein analysis 
using the microflow automated loop injection procedure as already described 
[10]. 
 
2.4 Identifying the HNE sequestering agents by an isotopic labelling 
procedure 
After filtration by using Amicon YM3 filters, the black rice giant germ extract 
(BRGE) was dissolved in PBS at a final concentration of 50 mg/mL and was 
then incubated in the absence and in the presence of HNE or deuterium 
labelled HNE (2H5-HNE).  After 24 hours the samples were analyzed 
individually by LC-MS together with a sample prepared by mixing in a 1:1 v:v 
ratio the samples incubated with HNE and 2H5-HNE .  
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Chromatographic separation was performed on a reversed-phase Agilent 
Zorbax SB-C18 column (150 x 2.1 mm, i.d. 3.5 µm, CPS analitica, Milan, Italy), 
protected by an Agilent Zorbax guard column, by an UltiMate 3000 system 
(Dionex) equipped with an autosampler kept at 4°C working at a constant flow 
rate (200 µL/min). 10 µL of sample was injected into the column and the 
analytes  were eluted with a 45 min multistep gradient of phase A 
H2O/HCOOH (100/0.1 % v/v) and phase B CH3CN/HCOOH (100/0.1 % v/v): 
0-5 min, isocratic of 1% B; 5-15 min, from 1% B to 25% B; 15-30 min, from 
25% B to 65% B; 30-32 min, from 65% B to 80% B; 32-36 min, isocratic of 
80% B; 36-36.1 min, from 80% B to 1 % B, and then 36.1-45 min of isocratic 
1% B. The acquisitions were performed on a LTQ-Orbitrap XL mass 
spectrometer using an ESI source, acquiring in positive and in negative ion 
mode. A real-time mass calibration was obtained by using a list of 20 
background ions [12]. The source parameters used for the positive mode are: 
spray voltage 3 kV, capillary temperature 275 °C, capillary voltage 49 V, 
sheath gas flow 15 units, auxiliary gas flow 5 units, tube lens offset 130 V; for 
the negative ion mode: spray voltage 3.5 kV, capillary temperature 275 °C, 
capillary voltage -17 V, sheath gas flow 15 units, auxiliary gas flow 5 units, 
tube lens offset -100 V. The instrument was set up to work in a data-dependent 
scan mode to acquire both full MS and MS/MS spectra. Full MS spectra were 
acquired in profile mode by the FT analyzer in a scan range of 100-1000 m/z, 
using AGC scan target 5 x 105 and resolution 100000 FWHM at 400 m/z. 
Tandem mass spectra were acquired by the linear ion trap (LTQ) that was set 
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up to fragment the 3 most intense ions exceeding 1 x 103 counts. Mass 
acquisition settings were: centroid mode, AGC scan target 1 x 104, precursor 
ion isolation width of 2.5 m/z, and collision energy (CID) of 30 eV. Dynamic 
exclusion was enabled to reduce redundant spectra acquisition: 2 repeat 
counts, 20 sec repeat duration, 30 sec of exclusion duration. Moreover, 
quaternary and more charged ions were not fragmented. Instrument control 
and spectra analysis were provided by the software Xcalibur 2.0.7 and 
Chromeleon Xpress 6.80. 
 
2.5 HPLC-UV HNE sequestering assay 
The compounds identified as putative HNE binders with the method described 
in section 2.4 were purchased as pure standards and tested individually for 
their HNE sequestering ability. The assay was a three-hour time course 
experiment at pH 7.4 and 37 °C, in the presence of 50 µM HNE and 1 mM of 
the tested compound. The residual HNE was measured hourly within a three-
hour reaction time by using the HPLC-UV assay described by Vistoli et al. [13] 
with some minor modifications. Briefly, HNE concentration was determined by 
a Surveyor HPLC platform (ThermoScientific, Milan, Italy) setting the UV 
detector at 224 nm. HNE elution was performed in 6 minutes by reverse phase 
chromatography at 37 °C and flow rate of 0.3 mL/min. A Kinetex column (75 
mm x 2.1 mm i.d., 2.6 μm particle size, 100 Å porosity, Phenomenex, Castel 
Maggiore, Italy) was used as stationary phase, while mobile phase consisted 
of H2O/CH3CN/ HCOOH, 80/20/0.1 (% v/v/v). 
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The amount of reacted HNE was calculated by the following formula: 
 
𝑟𝑒𝑎𝑐𝑡𝑒𝑑 𝐻𝑁𝐸 (%) =
[𝐻𝑁𝐸]𝑡0 − [𝐻𝑁𝐸]𝑡3
[𝐻𝑁𝐸]𝑡0
× 100 
 
[HNE]t0 being the concentration of HNE at the beginning of the incubation and 
[HNE]t3 being the concentration of HNE at the end of the incubation. 
Carnosine, which is a HNE sequestering agent not containing a thiol moiety, 
was used as positive control to assess the assay reproducibility. To 
demonstrate that HNE consumption over time is not caused by auto-oxidation, 
an incubation in pure phosphate buffer was performed as negative control. 
The activity of each compound was also given as Carnosine Units (i.e. the 
ratio between the % of HNE reacted with the compound at a given time and 
the % of HNE reacted with carnosine in the same span of time). 
 
3. Results and discussion 
3.1 Overview of the approach 
RCS are well known pathogenetic factors of various oxidative based diseases 
and recently molecular approaches based on their detoxification have been 
found effective in preventing the onset and progression of some diseases in 
different animal models. Among the different strategies aimed at detoxifying 
RCS, that based on small nucleophilic compounds capable of trapping and 
detoxify RCS is receiving a wide scientific interest. Several synthetic and 
natural RCS sequestering agents have so far been reported to be effective in 
III – Study 1 
29 
 
several animal models but for many of these compounds a clinical application 
is limited due to their promiscuous activity, lack of selectivity and of a suitable 
bioavailability. Hence, a discovery approach aimed at identifying novel RCS 
sequestering agents is welcome. In the present paper, we report a discovery 
approach aimed at identifying RCS sequestering agents in crude mixtures 
such as natural extracts. Natural sources and, in particular, plant extracts can 
represent a potential source of RCS sequestering agents, due to the fact that 
plants are also subject to RCS stress, in particular mediated by ,-
unsaturated aldehydes, and that they have developed efficient enzymatic and 
non-enzymatic detoxification pathways. Many non-enzymatic pathways and, 
in particular, those based on small nucleophilic agents are still unexplored and 
they would represent an interesting potential source of novel bioactive 
compounds. 
Searching for RCS sequestering agents in a crude mixture is quite a 
challenging process because they are usually present as minor components 
in respect to the complex matrix, making their identification and 
characterization a quite complex analytical challenge. Moreover, a robust 
method capable of measuring the overall RCS sequestering activity is needed 
in order to have an analytical tool able to select the most effective plant 
extracts where the bioactive components might be found.  
 
The approach here reported addresses this challenge and is based on the 
following steps: i) the RCS sequestering activity of the tested extracts is firstly 
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assayed by using the ubiquitin assay as previously reported; ii) the most active 
extracts are then selected for the second step which consists  of identifying 
the sequestering agents by using an innovative isotopic labelling procedure, 
iii) the RCS sequestering activities of the identified compounds are then 
validated by using standard compounds and using an HPLC-UV method. 
The method proposed has been applied by using HNE as target aldehyde and 
eight rice extracts as potential sources of RCS sequestering agents. HNE is 
an α,β-unsaturated aldehyde generated endogenously and exogenously (it is 
present in food) by the radical-mediated peroxidation of ω-6 polyunsaturated 
fatty acids. Since its identification, 4-hydroxy-nonenal (HNE), an autoxidation 
product of unsaturated fats and oils, (at first erroneously described as 4-
hydroxy-octenal) [14] has attracted great scientific interest, as demonstrated 
by the publication of more than 4200 papers since 1980. Compared to other 
4-hydroxyalkenals, HNE is the most extensively studied and reviewed as it 
was the first one discovered [14], it represents the main 4-hydroxyalkenal 
formed during the autoxidation of unsaturated fatty acids [15], it is highly 
reactive [16] and numerous biological effects have been demonstrated [15], 
leading HNE being considered as a promising drug target. 
Rice (Oryza sativa) is one of the five different cereal grains, which are the 
most commonly consumed throughout the world and are functionally reported 
to have antioxidant activity. Bioactive components of rice, have demonstrated 
antioxidant and anti-inflammatory activities in cells and animals [17, 18]. 
However, although the direct and indirect antioxidant activity of rice has been 
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demonstrated in different in vitro and also in vivo models, no data to our 
knowledge have so far been reported regarding the efficacy of rice towards 
protein carbonylation and in particular on its effect to sequester RCS. We then 
decided to apply the proposed method to test the RCS sequestering capability 
of rice and for this we evaluated the water extracts of white, brown and black 
rice.  
 
 
3.2 HNE sequestering activity of rice extracts 
The overall HNE sequestering activity of eight rice extracts was studied using 
the ubiquitin assay as previously reported. The method consists of incubating 
ubiquitin as protein target with HNE at a specific molar ratio and incubation 
time, thus inducing ubiquitin covalent modification of almost 50%. The protein 
carbonylation was monitored by measuring the ratio of the areas of two peaks: 
one at m/z 779.61239 relative to the 11-charged peak (named z11) of native 
ubiquitin and the second at m/z 793.80415 corresponding to the 11-charged 
peak of ubiquitin covalently modified by HNE. Figure 1 shows the MS spectra 
of ubiquitin incubated in the absence and in the presence of HNE. When 
ubiquitin incubated with HNE was spiked with rice extracts, a dose-dependent 
reduction of the peak area relative at m/z 793.80415 was observed. The IC50 
value, which is the rice extract concentration able to decrease by 50% the 
level of protein carbonylation, was determined. Table 1 summarizes the IC50 
of the tested rice extracts. White rice extract was found less effective in 
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respect to colored rice and of these, black rice with giant embryo was the most 
effective and for this reason, it was selected for the next step aimed at 
identifying the compounds responsible for the sequestering effect of the 
extract. 
 
 
 
 
Figure 1 – 11-charged MS peaks of ubiquitibìn incubated in the absence and in the presence 
of HNE and increasing concentration of two extract: white rice extract (panel on the left) and 
BRGE (panel on the right). 
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Table 1 - HNE sequestering activity of rice extracts. Activities are reported as IC50 which 
represents the concentration of the tested compound able to reduce by 50% HNE-induced 
ubiquitin carbonylation. 
 
 
3.3 Set-up of an isotopic labelling procedure for the identification of HNE-
sequestering agents 
An off-target approach based on isotopic signature was then set-up to identify 
HNE adducted compounds when present in complex matrices such as plant 
extracts. As summarized in Figure 2, the method consists of the following 
steps: i) the plant extract is spiked with HNE (156.11502 Da) and 2H5-HNE 
(161.07590 Da) mixed at the same molar ratio. Compounds which are reactive 
towards HNE, react with both the isotopes at the same rate forming reaction 
products which have a specific isotopic pattern, a pair of peaks with a similar 
intensity spaced by the delta mass corresponding to the incremental mass of 
2H5-HNE in respect to HNE (5.03088 Da ± 10 ppm).  
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The second step consists of extracting the m/z values relative to the ions of 
the HNE adducts. This is automatically carried out by Compound Discoverer™ 
on the basis of the specific isotopic pattern characterized by the two peaks 
with the same intensity and with a delta mass corresponding to five deuterium 
atoms. Figure 3 shows in more detail the specific workflow generated to 
extract the peak lists from the mass spectra. By setting the “Pattern Tracer” 
node with a delta mass of 5.03088 Da, a chromatogram of the peak pairs 
characterized by the set delta mass was obtained. Elution times of the most 
abundant peaks were then extracted and the m/z values of each peak pair 
were then obtained by the TIC chromatogram. HNE adducts were then 
confirmed by manually inspecting the characteristic relative abundance and 
mass shift of the isotopic pattern.  
Further confirmation of the identity of the HNE adducts was given by the 
Unknown Detector node which checks for the absence of the detected peaks 
as above reported in non-spiked samples. 
 
Figure 2 – Graphic representation of the method 
III – Study 1 
35 
 
 
 
As a final confirmation of the adduct, the MS/MS spectra of each ion of the 
isotopic pattern (non deuterated and deuterated ions) were checked in order 
to verify the overlap between the spectra, thus confirming the same structures 
and avoiding false positives. The M.W of the bioactive compounds were then 
calculated by subtracting the M.W. of the HNE molecule (156.11502 Da) from 
the masses of the identified compounds, and assuming that the detected ions 
are attributed to the Michael adduct between HNE and the bioactive molecule 
(as reported for a series of bioactive molecules able to quench HNE [19]). 
 
 
 
Figure 3 - Workflow’s nodes used in Compound Discoverer. 
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3.4 Identification of sequestering components in black rice with giant embryo 
Figure 4 shows the pattern trace of BRGE incubated in the presence of HNE 
and 2H5-HNE mixed at the same molar ratio. Eleven peaks over the threshold 
intensity were easily identified and their HNE adducted nature was confirmed 
by manual inspection taking into account the mass shift between the ion pairs, 
their relative abundances and the overlapping MS/MS fragmentation pattern.  
 
 
 
The MW of the sequestering agents were then determined by subtracting the 
MW of the adducts from that of HNE. The identity of the parent compounds 
was then assigned by matching the experimental accurate masses and 
MS/MS fragment ions with those contained in a database of compounds 
present in plants by using VEGA ZZ software (http://www.vegazz.net/). The 
database contained 6584 entries. Moreover the research was also performed 
on ChemSpider. A list of nine compounds with a MW lower than 350 Da was 
then obtained and listed in Table 2.  
Figure 2 - The “pattern tracer” chromatogram obtained by Compound Discoverer of BRGE 
+ HNE + 2H5-HNE (negative ion mode). 
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Quencher 
monoisotopic  
MW 
Calculated 
MW 
Δppm Possible structure 
103.06336 103.06333 0.304 γ-Aminobutirric acid 
155.06950 155.06948 0.151 Histidine 
165.07922 165.07898 1.462 Phenylalanine 
271.06133 271.06064 2.514 Pelargonidin 
301.07236 301.07121 3.809 Peonidin 
317.06864 317.06612 7.923 Petunidin 
317.12164 317.12229 -2.082 Asp-Ser-Pro 
330.07634 330.07395 7.232 Tricin 
331.08361 331.08177 5.533 Malvidin 
 
Table 2 - HNE quenchers identified in rice extract BRGE by using the isotopic labelling 
procedure. 
 
Five out of 9 compounds were flavonoids, four of them belonging to the 
anthocyanins class, three compounds were aminoacids, two of them 
proteogenic, while one a peptide.   
 
 
3.5 HNE sequestering activity  
The commercially available compounds identified as described in section 3.4 
were then tested as HNE sequestering agent by using an HPLC-UV test. The 
test is based on measuring free HNE after incubating the tested compound 
with HNE. Table 3 reports the percentage of HNE sequestered by the active 
compounds identified in BRGE extract. Results are reported either as % of 
HNE consumption at 1 and 3 hours and as carnosine units at 1 and 3 hours, 
setting as 1 the value of carnosine activity for both the time points. Histidine, 
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phenylalanine and aminobutyric acid were the aminoacids identified as having 
HNE sequestering activity. The reactivity for histidine is due to the imidazole 
ring as has already been reported, together with the full elucidation of the 
reaction adduct by NMR. The activity of histidine is increased when bonded 
to specific aminoacids such as beta-alanine as in the case of carnosine or 
analogues which are histidine peptides found in mammals. However, no 
histidine peptides were detected as HNE adducts in the rice extract. The HNE 
sequestering activity of GABA and phenylalanine, which is more likely due to 
their primary amino group, is very weak and much lower in respect to that of 
carnosine (the HNE sequestering activity was under the detection limit as 
determined by using the HPLC-UV assay). However, even if these two 
compounds are characterized by a very low potency as HNE sequestering 
agents in comparison to that of carnosine, they act as HNE sequestering 
agents in the crude mixture. This apparent contradiction could be explained 
by considering that they are probably contained in high concentrations in the 
extract or could be explained by the specific milieu which catalyses their 
reactions. In other words, it should be considered that the overall sequestering 
efficacy of compounds in plant extracts is not only due to their intrinsic 
nucleophilic reactivity but also to their relative concentration as well as to the 
matrix which could affect the intrinsic activity itself.  
A set of polyphenols were then identified as HNE sequestering agents, four 
anthocyanidins and one flavone (tricin). All the identified compounds were 
found less effective than carnosine but they were characterized by a well 
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detectable activity in the HPLC-UV assay. Among these polyphenols, 
pelargonidin was the most potent, followed by tricin, peonidin and malvidin. 
The activity of anthocyanindins as HNE sequestering agents which are 
characteristic components of black rice can also explain the higher overall 
activity of black rice in respect to white rice and to the other rice varieties. 
 
Table 3 - HNE sequestering activity of standard compounds identified in rice extract 
BRGE. The activity was determined by measuring free HNE by HPLC-UV analysis  
 
ACTIVITY 
(CARNOSINE UNITS) 
HNE CONSUMPTION 
(%) 
1h 3h 1h 3h 
REFERENCE COMPOUNDS 
BUFFER <0.1 <0.1 0.17±0.31 0.71±0.67 
CARNOSINE 1.00 1.00 13.78±2.34 36.06±4.98 
POLYPHENOLS 
PEONIDIN-GLUCOSIDE 0.29 0.20 4.00±1.39 7.27±2.42 
MALVIDIN (anthocyanidin) <0.1 <0.1 1.15±1.10 1.87±1.35 
PEONIDIN (anthocyanidin) <0.1 0.12 1.02±0.47 4.31±0.92 
PELARGONIDIN 
(anthocyanidin) 
0.57 0.35 7.81±0.49 12.60±1.99 
TRICIN-GLUCOSIDE (o-
methylated flavone) 
0.30 0.20 5.03±2.58 8.31±2.91 
AMINOACIDS 
PHENYLALANINE <0.1 <0.1 0.84±0.78 1.28±0.47 
GABA <0.1 <0.1 0.34±0.59 0.35±0.62 
HISTIDINE 0.12 0.17 1.77±1.82 6.26±2.69 
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4. Conclusions 
In conclusion, we here report a novel approach which permits the screening 
of plant extracts and in general complex matrices for their overall activity as 
HNE sequestering agents and the identification of small molecules 
responsible for the sequestering effects. The approach could be applied to 
screen a variety of plant extracts with the final aim of identifying novel and 
potent HNE sequestering agents. The methods can also be easily adapted to 
other cytotoxic RCS compounds such as MDA, glyoxal and methylglyoxal for 
which potent sequestering agents are yet to be found. 
 
By using this assay, we also found that rice and in particular black rice is a 
valuable source of detoxifying agents of HNE which is known to be formed 
during food digestion and has a role in the promotion of colon cancer (Bastide 
et al., 2015). HNE derived from food is estimated to be 16 μg day-1 as daily 
exposure in korean food for a 60 Kg korean adult (Surh and Kwon, 2005). 
Based on the fact that 29.1 mg, corresponding to 673 mg black rice, inhibits 
50% of protein carbonylation induced by 78.0 μg ml-1 of HNE we can easily 
conclude that the HNE daily exposure of 16 μg day-1 should be easily 
detoxified by a serving portion of 75 gr.  
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Abbreviations: RCS, reactive carbonyl species; AGEs, advanced glycation 
end-products; ALEs, advanced lipoxidation end-products; HNE, 4-Hydroxy-2-
nonenal; ACR, acrolein; EGCG, epigallocatechin-gallate; MGO, 
methylglyoxal; MDA, malondialdehyde; BRGE, black rice with giant germ 
extract; HNE-DEA, 4-Hydroxy-2-nonenal diethylacetal; 2H5-HNE-DEA, 2H5-4-
Hydroxy-2-nonenal diethylacetal. 
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Development of a direct ESI-MS method to measure the 
tannin precipitation effect of proline rich peptides 
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Abstract 
Tannins are a heterogeneous class of polyphenols that are present in several 
plants and foods. The ability of such molecules to interact and precipitate 
proline-rich proteins leads to different effects such as astringency or 
antidiarrheal activity. Thus, it is important to evaluate tannin content in plant 
extracts to evaluate their potential use as pharmaceutical and nutraceuticals. 
Several methods have been proposed to study tannin-protein interaction but 
few of them are focused on quantification. The purpose of the present work is 
to set up a suitable and time efficient method able to quantify the extent of 
tannin protein precipitation. Bradykinin, chosen as a model, was incubated 
with increasing concentrations of 1,2,3,4,6-pentagalloyl β-D-glucose and 
tannic acid chosen as reference of tannic compounds. Bradykinin not 
precipitated by tannins was determined by a mass spectrometer TSQ 
Quantum Triple Quadrupole equipped with an ESI source (direct infusion 
analysis). The results were expressed as PC50, which is the concentration able 
to precipitate 50% of the target protein. The type of tannin-protein interaction 
was also evaluated after precipitate solubilization. The involvement of proline 
residue in tannin-protein interaction was confirmed by repeating the 
experiment using a synthesized peptide (RR-9) characterized by the same 
bradykinin sequence, but having proline residues replaced by glycine 
residues: no interaction occurred between the peptide and the tannins. 
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1. Introduction 
Tannins are a heterogeneous class of polyphenols that are present in several 
plants and foods, such as fruits, cereals, wine, tea, cocoa and vegetables [1]. 
According to Bate-Smith and Swain, tannins are water-soluble phenolic 
compounds with a molecular weight between 500 and 3000 Da, characterized 
by many hydroxyl groups and capable of forming cross-linkages with proteins. 
These compounds are classified as hydrolysable and condensed tannins. 
Hydrolysable tannins are made of a monosaccharide core, such as glucose, 
partially or completely esterified with an organic acid, such as gallic acid 
(gallotannins) or ellagic acid (ellagitannins)  [2]. Condensed tannins are more 
complex than hydrolysable tannins: they are polymers of flavan-3-ols linked 
through acid-labile carbon-carbon bonds [3].  
As secondary metabolites of plants, tannins have a role in plant defense, 
discouraging herbivores from feeding on the plant. These compounds are also 
used in the production of leather and their level needs to be controlled in wine 
production to reduce astringency. All these actions are related to the effect of 
tannins in inducing protein precipitation. In particular, the interaction is known 
to occur between tannins and proteins rich in proline residues (PRPs) [4].   
More recently, the protein precipitation effects induced by some plant 
components has also been considered to explain some bioactive actions. 
Such effects occur when the precipitating protein (protein target) has a 
damaging effect or is contained in infectious organisms. Based on such a 
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mechanism, tannins and plant extracts rich in tannins have been proposed as 
antidiarrheal [5], antiviral [6, 7], antibacterial agents  [8-10] and to neutralize 
the toxic activities of snake venoms [11]. Moreover, a fully detailed study on 
the molecular interaction of tannin and in particular of penta-O-galloyl-d-
glucopyranose with bradykinin has been carried out by NMR. Bradykinin is a 
proline-rich peptide (Pro residues accounting for 30% of the residues) which 
acts as an inflammatory mediator and its complexing by tannin can partially 
explain the well-known anti-inflammatory properties of such a class of 
compounds. More recently, the molecular interaction between tannin and 
different wheat-derived peptidic fractions which contain a high content of 
proline residues and which are responsible for the onset of celiac disease has 
been studied. This study indicates that the aggregation between tannins and 
immunoreactive peptides could represent an important field in the potential 
protective effect of tannins on the cytotoxicity and/or the immunogenicity of 
gluten peptides. 
Based on these recent findings it seems that beside salivary rich peptides 
such histatins, interaction of tannins with bioactive proline rich peptides 
deserves some interest; in particular a valuable method able to measure the 
precipitating effect of tannins towards damaging peptides could be useful in 
order to identify potential bioactive compounds and/or plant extracts 
containing them.  
The aim of the present work is to set-up an analytical method able to measure 
the ability of tannins and/or plant extracts to interact with and precipitate 
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peptides rich in proline. Bradykinin was chosen as a target for tannin binding 
not only because it is a peptide rich in proline residues, but also due to its 
involvement in inflammatory disorders such allergies and the common cold, 
hence representing a potential target peptide of the tannin precipitation effect. 
Tannic acid (TA) and penta-O-galloyl-β-D-glucose (PGG) were used as 
reference compounds of tannins. 
 
 
2. Materials and Methods 
2.1 Chemicals and reagents 
HPLC-grade water was prepared with a Milli-Q water purification system 
(Millipore, Milan, Italy). Ammonium acetate was from Riedel-de Haën (Seelze, 
Germany). Bradykinin acetate, tannic acid (TA), penta-O-galloyl-β-D-glucose 
(PGG), formic acid and LC-grade and analytical-grade organic solvents were 
from Sigma-Aldrich (Milan, Italy). The internal standard peptide LVNEVTEF 
was custom synthesized by Sigma-Aldrich (Milan, Italy). The peptide RR-9 
RGGGFSGFR was synthesized by PRIMM (Milan, Italy). 
2.2 Bradykinin-tannin co-precipitation assay 
Bradykinin 100 µM was dissolved in 50 mM acetate buffer pH 7.4 and 25 µL 
samples were spiked with of PGG or TA at the following concentrations: 10 
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(only for PGG), 50, 100, 150, 200, 250, 500, 1000 (only for TA) µM performed 
in 3 replicates. The mixtures were incubated for 10 minutes at 37°C under 
gentle shaking (1400 rpm on a Thermomixer) and then centrifuged for 10 
minutes at 14000 rpm. The supernatant (25 µL) was diluted 1:10 with 
H2O/CH3CN/HCOOH (70/30/0.1, % v/v), spiked with the peptide LVNEVTEF 
as internal standard (10 µM final concentration) and analysed by direct 
infusion MS as below detailed in order to quantify the amount of bradykinin 
not precipitated by tannins. The precipitates were then dried, dissolved in 
H2O/CH3CN/HCOOH (70/30/0.1, % v/v) and analysed by MS in order to verify 
the presence of bradykinin.  
2.3 Supernatant and precipitate analyses by mass spectrometry 
30 µL of the supernatant was injected by an automated sample injection into 
a TSQ Quantum Ultra Triple Quadrupole (Thermo Finnigan, Milan, Italy) 
equipped with an ESI-source. An HPLC Surveyor MS Pump (Thermo 
Finnigan, Milan, Italy) pumped the sample at 25 µL/min with an isocratic phase 
H2O/CH3CN/HCOOH (70/30/0.1, % v/v). The analyses were performed in 
positive ion mode and with the following ion source parameters: capillary 
temperature 270° C; spray voltage 4.5 kV; capillary voltage 35 V; tube lens 
voltage 114 V. The flow rate of the nebulizer gas (nitrogen) was 15 a.u. The 
mass spectrometer operated in full mass scan and the Q3 was used as 
detector with a scan range 450-1300 m/z. 
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Xcalibur 2.0.7 version was used for the relative quantification of bradykinin. A 
processing method was set up in order to obtain an automated integration of 
the areas of the z = 2 (m/z 530.9) and z = 1 (m/z 1060.6) peak of bradykinin 
and z = 1 (950.5 m/z) peak of the internal standard. The ICIS peak integration 
parameters set were: smoothing points 7; baseline window 40; area noise 
factor 5; peak noise factor 10; minimum peak high (S/N) 3. This processing 
method was applied in the Quan Browser window of Xcalibur for the analysis 
of all the samples. The results were verified and manually corrected where the 
integrations were not appropriate. 
20 µL of the precipitate dissolved was injected by an automated sample 
injection into a LTQ -Orbitrap XL mass spectrometer (Thermo Scientific, Milan, 
Italy) equipped with an ESI-source. An HPLC UltiMate 3000 (Thermo 
Scientific, Milan, Italy) pumped the sample at 25 µL/min with an isocratic 
phase H2O/CH3CN/HCOOH (70/30/0.1, % v/v). The analyses were performed 
in positive ion mode and with the following ion source parameters: capillary 
temperature 270° C; spray voltage 4.5 kV; capillary voltage 35 V; tube lens 
voltage 114 V. The flow rate of the nebulizer gas (nitrogen) was 15 a.u. After 
mass spectrometry analysis, the deconvolution was carried out with MagTran 
1.02 software.  
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3. Results 
3.1 Set-up of a ESI-MS method to measure the tannin precipitation effect 
Several ESI-MS approaches have been reported to better understand the 
non-covalent interaction between tannins and peptides, which in particular 
have been found suitable for the study of the (1) molecular interactions, (2) 
the binding stoichiometry and (3) the evaluation of the complex stability.  
To our knowledge, no studies based on MS have been reported for the 
measurement of the precipitating effect of tannins towards proline rich 
peptides, which is the aim of this paper. Bradykinin was selected as target 
peptide and tannic acid (TA) and penta-O-galloyl-β-D-glucose (PGG) as 
reference compounds of tannins.  
Figure 1 summarizes the assay. After incubating the target peptide with tannin 
at different final concentrations, the sample is centrifuged and the relative 
content of the target peptide in the supernatant determined by ESI-MS using 
LVNEVTEF as internal stdandard. The precipitating effect is determined by 
calculating the residual amount of the target peptide in the supernatant in 
relation to a sample containing the target peptide and prepared in absence of 
tannins (100% of the peptide).  
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Figure 2 shows the ESI-MS spectra of bradykinin spiked with the internal 
standard. The ions at m/z 530.9 and m/z 1060.6 refer to the [M+2H]2+ and 
[M+H]+ of bradykinin, respectively, while the ion at m/z 950.5 is attributed to 
the [M+H]+ of the internal standard.   
 
Figure 1 – Graphic representation of the bradykinin precipitation assay 
Figure 2 – ESI-MS spectrum of a solution of bradykinin (10 µM) spiked with the IS. Ions at 
530.9 m/z and 1060.6 m/z are the [M+2H]2+ and [M+H]+ of bradykinin, respectively. The ion at 
950.5 m/z refers to the [M+H]+ of the internal standard. 
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In preliminary experiments carried out by LC-ESI-MS/UV, both TA and PGG 
up to a concentration of 1 mM did not significantly precipitate the IS. As shown 
in Figure 3A, the intensity of bradykinin peaks (but not that of the internal std.) 
decreases as the concentration of TA increases. Figure 3B shows the dose 
dependent precipitating effect of TA which started at 50 µM (% of residual 
bradykinin = 87.8812.52) and reached a plateau at 500 µM (13.0012.36%).  
 
 
Figure 3 - Dose-dependent precipitating effect of Bradykinin induced by TA. A) Tannic Acid 
dose-dependently reduces the relative abundance of the ion at m/z 530.9 refers to 
bradykinin [M+2H]2+ in respect to the abundance of the ion at m/z 950.5 attributed to the 
internal standard (LVNEVTEF). TA concentrations: 0 µM (a), 50 µM (b), 100 µM (c), 150 
µM (d), 200 µM (e), 250 µM (f), 500 µM (g), 1000 µM (h). B) Plot showing the residual 
bradykinin in respect to TA concentration. Values are mean ± SD of three replicates. C) 
Mean % of residual bradykinin for each concentration tested. 
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Figure 3C reports the % of residual bradykinin values for each concentration 
tested. A similar precipitating effect was observed for PGG (Figure 4A, B and 
C).  
The protein precipitation potency for each tannin was then quantified as the 
concentration able to precipitate the 50% of bradykinin (100µM) (PC50). The 
calculated values are 112.3 µM and 84.6 µM for TA and PGG, respectively. 
 
 
 
Figure 4 - Dose-dependent precipitating effect of Bradykinin induced by PGG. A) PGG dose-
dependently reduces the relative abundance of the ion at m/z 530.9 refers to bradykinin 
[M+2H]2+ in respect to the abundance of the ion at m/z 950.5 attributed to the internal 
standard (LVNEVTEF). TA concentrations: 0 µM (a), 10 µM (b), 50 µM (c), 100 µM (d), 150 
µM (e), 200 µM (f), 250 µM (g), 500 µM (h). B) Plot showing the residual bradykinin in respect 
to TA concentration. Values are mean ± SD of three replicates. C) Mean % of residual 
bradykinin for each concentration tested. 
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To confirm the presence of bradykinin in the precipitates, the pellet obtained 
by precipitation was dissolved in H2O/CH3CN/HCOOH (70/30/0.1, % v/v) and 
analysed by direct infusion in a LTQ-Orbitrap XL mass spectrometer. Figures 
5 and 6 show the presence of [M+3H]3+ and [M+2H]2+ ions of bradykinin 
without any covalent adduct with TA and PGG, as can be appreciated by the 
deconvoluted spectra.  
 
Figure 5 – Analysis of the precipitate occurred between TA and bradykinin: in the upper 
panel the spectrum of [M+3H]3+ and [M+2H]2+ bradykinin ions; in the lower panel the 
deconvoluted spectrum obtained with MagTran confirms the identity of bradykinin 
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3.2 Study of the involvement of proline residues in bradykinin precipitation 
In order to understand the involvement of Pro residues in bradykinin 
precipitation an analogue peptide (RR-9) where the Pro residues are replaced 
by Gly was tested. Figure 7 shows the MS spectrum of RR-9 characterized by 
the ions at m/z 470.7 and 940.2 which represent the [M+H]+ and [M+2H]2+ 
ions, respectively.  PGG was then selected as precipitating tannin. As shown 
in Figure 8 PGG did not induce any significant precipitating effect up to 250 
µM while only a weak effect was observed at 500 µM.   
Figure 6 -  Analysis of the precipitate occurred between PGG and bradykinin: in the 
upper panel the spectrum of [M+3H]3+ and [M+2H]2+ bradykinin; in the lower panel the 
deconvoluted spectrum obtained with MagTran confirms the identity of bradykinin. 
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Figure 7 - ESI-MS spectrum of a solution of RR-9 (10 µM) spiked with the IS. Ions at 470.7 
m/z and 940.2 m/z are the [M+2H]2+ and [M+H]+ of RR-9, respectively. The ion at 950.5 m/z 
refers to the [M+H]+ of the internal standard 
Figure 8 - Profile of RR-9 reduction in the supernatant by PGG increasing concentration 
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4. Discussion 
Several methods have been set-up to measure the protein precipitation effect 
of tannins and the most popular are those based on BSA as protein target and 
colorimetric assays to measure the unbound protein fraction in the 
supernatant or tannins in the precipitated protein-tannin fraction. Makkar HP 
et al. [12] determined the precipitated BSA by ninhydrin assay and Haruo 
Kawamoto et al. [13] quantified the precipitated BSA by HPLC-UV. Two 
methods were based on the use of filter disk and membrane after tannin 
fractions or plant extract immobilization on these kind of surface: the extent of 
the interaction was determined as reduction of the BSA diffusion [14] or by 
gamma counting of BSA 125I-labelled adsorbed [15]. Scott H. et al. reported a 
miniaturized method [16] which aimed to reduce the amount of volume in the 
assay by using a microplate to measure the unprecipited BSA by the Bradford 
assay. On the other hand, some methods were based on the analysis of tannin 
co-precipitated fraction after solubilization of the precipitate by reaction with 
ferric chloride followed by quantification of the total absorbance (510 nm) [17, 
18].  
However, such methods are not suitable for the measurement of the 
precipitation of target peptides when used at micromolar level and contained 
in small sample volumes (not higher one than hundred microliters). Such 
conditions are required when using bioactive peptides which are expensive or 
difficult to synthesize and/or isolate. The method here reported fulfills these 
requirements since the volume of the samples is in the order of hundreds of 
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microliters and the concentration of the target peptides is in a micromolar 
range, depending on the MS analyzer used. In the present work, by using 
triple quadrupole, which is a quite common instrument, the peptide was used 
at a final concentration of 100 micromolar but the concentration could be 
further reduced when more sensitive analyzers, such as qTOF or orbitraps, 
are available. Moreover, the sample volumes can be further reduced if micro-
wells are used and in this case a high throughput method can also be adapted. 
Despite the fact that the triple quadrupole mass spectrometer is not the best 
instrument in terms of sensitivity when used in full MS acquisition mode, good 
reliability and precision can be reached and better results can be obtained if 
compared to colorimetric assays. 
 
5. Conclusions 
In conclusion, an in vitro method was set-up for the quantitative determination 
of the tannin precipitation effect of proteins and proline rich peptides. The 
method could be useful to test the ability of tannin to precipitate and hence 
inactivate damaging peptides and also to evaluate the selectivity of the 
precipitation effect. Some proline rich peptides can be considered as potential 
targets of tannins such as bradykinin, an inflammatory mediator, and wheat-
derived peptidic fractions which contain a high content of proline residues and 
which are responsible for the onset of celiac disease.  The method could be 
applied to isolated compounds as well as to complex matrices such as plant 
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derivatives and fractions. The precision of the method was found satisfactory 
since the CV% was always lower than 20% for all the concentrations tested. 
Finally, the method is time efficient thus permitting the rapid screening of 
several plant extracts and compounds able to complex and precipitate 
damaging target peptides.  
 
Abbreviations: TA, tannic acid; PGG, penta-O-galloyl-β-D-glucose; PRPs, 
proline rich proteins; BSA, bovine serum albumin. 
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Abstract 
C. albicans is one of the causes of nosocomial urinary tract infections (UTIs).  
Cranberry (V. Macrocarpon) is a natural source of polyphenols widely used 
for the treatment of some diseases including UTIs. Nevertheless, there are 
many conflicting results regarding the active component and this is due to the 
use of different dosages and non-standardized Cranberry treatments. The 
purpose of this work was to fully profile the components and metabolites in 
human urine after ingestion of a standardized Cranberry extract (Anthocran™) 
at a dosage which was found effective in human studies. An HPLC-MS/MS 
method was set up to characterize the profile of cranberry components and 
metabolites in human urine collected from four female volunteers after 7 days 
of Anthocran™ assumption. Two different strategies were adopted for the data 
analysis: an on target and an off target approach. CFM-ID (competitive 
fragmentation modeling for metabolite identification) was used for the 
identification of the unknown ions. These strategies allowed the identification 
of 35 analytes including Cranberry components, known metabolites and also 
metabolites hitherto unreported in the literature. Urine collected at different 
time ranges (1, 2, 4, 6, 10, 12, 24 hours) after the last dosage of Anthocran™ 
were ex-vivo tested on the reduction of C. Albicans adhesion. Fractions 
collected after 1 and 12 hours were found effective, reducing significantly 
reduce the adhesion compared to the control (p < 0.001). Purified Anthocran™ 
components and metabolites identified in the two active urine fractions will be 
tested. 
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1. Introduction 
Candida albicans is one of the few fungal pathogens that can cause infections 
in humans [1] and it is one of the most frequently isolated pathogen in 
nosocomial urinary tract infections (UTIs) [2]. Urological devices, urological 
procedures, diabetes and being female are the main factors linked to 
candiduria [3]. Catheters, which are used in up to 20% of hospitalized subjects 
[4], are good adhesion substrates for microorganisms as well as biofilms 
proliferation surfaces. The most important feature of biofilms is their resistance 
to antimicrobial therapies [5]. Therefore, the search for new antifungal agents 
is necessary and it should be focused on plants active compounds.  
Cranberry (Vaccinium macrocarpon) is a rich source of polyphenols, which 
possess beneficial properties towards pathogenic infections including urinary 
tract infections (UTIs), dental caries and stomach ulcers [6]. Moreover berry 
phenolics showed antioxidant, anti-inflammatory and anticancer properties [7, 
8]. A synergy of all the phytochemicals could explain the great cranberry 
health benefits reported in in vitro studies [9-11]. Despite all these potential 
applications, cranberry based products are commonly used in the prevention 
of UTIs [12]. The major constituents of cranberry are flavonols, anthocyanins, 
PACs, flavan-3-ols and phenolic acids and derivatives [13]. Several in vitro 
studies supported the hypothesis that the antiadhesive properties of cranberry 
are due to PACs, and in particular to the A-type [14]. However, controversial 
results regarding their presence in human urine are reported: many in vivo 
studies have demonstrated that they are not detected after cranberry intake 
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[15-18], but two works have shown their presence in urine at a very low 
concentration [19, 20]. The use of different dosages and non-standardized 
cranberry products could explain these controversial results. The purpose of 
the present work is to profile the components and metabolites in human urine 
after ingestion of a standardized cranberry extract (Anthocran™, Indena 
S.p.A.) at a dosage which has been found effective in human studies [21, 22]. 
Furthermore, an evaluation of the activity of urine samples after cranberry 
intake on C. albicans adhesion was performed in order to isolate the bioactive 
molecules.  
 
2. Materials and Methods 
2.1 Reagents 
Formic acid, orthophosphoric acid, ammonium acetate, ethyl gallate, LC–MS 
grade solvents and β-glucuronidase from Helix Pomatia (Type HP-2, ≥ 
100,000 units/mL) were purchased from Sigma–Aldrich (Milan, Italy). LC-
grade H2O (18 MΩ cm) was prepared with a Milli-Q H2O purification system 
(Millipore, Bedford, MA, USA). SPE Hypersep C18 column (100 mg/mL) were 
from Thermo Scientific (Milan, Italy). Standardized cranberry extract (V. 
Macrocarpon) and the capsules containing 36 mg PACs/capsule 
(Anthocran™) were generously donated by Indena S. p. A (Milan, Italy). 
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2.2 Study design on healthy volunteers 
Four young healthy female volunteers were recruited for the study: mean age 
25 years, mean body weight 55 kg, non-smoker, not subjected to 
pharmacological treatments. They followed a diet low in polyphenols for 72 
hours before the treatment and during the assumption of cranberry 
supplement. The diet excluded: fruits and vegetables rich in polyphenols, 
chocolate and some beverages such as coffee, tea, wine and fruit juice. The 
aim was to reduce as much as possible the concentration of polyphenols in 
biological fluids. The subjects assumed 2 capsules Anthocran™/day for 7 
days. Urine samples were collected before and after the following time-point: 
1, 2, 4, 6, 10, 12, 24 hours. Ethyl gallate 10 µM was added as internal standard 
and all the samples were stored at -80°C until analysis. 
2.3 Sample preparation 
1.5 mL of a pool of the 4 subject urines were treated with β-glucuronidase 
from Helix Pomatia (5000 U/1.5mL urines) in 100 mM pH 5 acetate buffer, for 
18 hours at 37°C. The hydrolysis was stopped by adding orthophosphoric acid 
until pH 2 was reached. The samples were then centrifuged at 10000 xg for 5 
minutes and the supernatant was extracted on the SPE column, working at 1 
mL/min. Salts were removed with water and then all the compounds retained 
were eluted with 1 mL 100% acetonitrile. The fractions collected were dried 
under vacuum and then solubilized in 100 µL H2O/CH3OH/ HCOOH (90/10/0,1 
% v/v). 
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2.4 Chromatographic conditions 
Cranberry components and urine metabolites separations were performed on 
a reversed-phase Agilent Zorbax SB-C18 column (150 x 2.1 mm, i.d. 3.5 µm, 
CPS analitica, Milan, Italy), protected by an Agilent Zorbax guard column, kept 
at 40°C, by an UltiMate 3000 system (Dionex) equipped with an autosampler 
kept at 4°C working at a constant flow rate (200 µL/min). 10 µL of sample was 
injected into the column and both cranberry components and urine 
metabolites were eluted with a 80 min multistep gradient of phase A 
H2O/HCOOH (100/0.1 % v/v) and phase B CH3CN/HCOOH (100/0.1 % v/v): 
0-45 min, from 10% B to 20% B; 45-65 min, from 20% B to 60% B; 65-66 min, 
from 60% B to 90% B; 66-70 min, isocratic of 90% B; 70-71 min, from 90% B 
to 10 % B, and then 71-80 min of isocratic 10% B. 
2.5 Polyphenol class identification by HPLC-UV analysis 
The identification of polyphenol classes was carried out by HPLC-UV analysis 
on a HPLC Surveyor LC system (Thermo Fisher Scientific, Milan, Italy) 
equipped with a quaternary pump, UV-VIS detector (PDA) and an 
autosampler. The scan range was set from 200 nm to 600 nm. A solution of 4 
mg/mL of cranberry extract in H2O/CH3OH/HCOOH (90/10/0.1 % v/v) was 
used for the analysis. 
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2.6 Cranberry component profiling and urine metabolites characterization by 
high resolution mass spectrometry 
10 µL of each sample was injected into the RP column as previously 
described: the cranberry extract was analyzed at a concentration of 4 mg/mL 
in H2O/CH3OH/HCOOH (90/10/0.1 % v/v), while the urine samples were 
analyzed after the treatment described in par. 2.3. The analyses were 
performed on a LTQ-Orbitrap XL mass spectrometer using an ESI source. 
Mass spectra were acquired in positive and in negative ion mode. A list of 20 
background ions was adopted as lock mass values for real time mass 
calibration [23]. The source parameters used for the positive mode are: spray 
voltage 4 kV, capillary temperature 300 °C, capillary voltage 30 V, tube lens 
offset 90 V; for the negative ion mode: spray voltage 4 kV, capillary 
temperature 300 °C, capillary voltage -23 V, tube lens offset -140 V. The 
instrument was set up to work in a data-dependent scan mode to acquire both 
full MS and MS/MS spectra. Full MS spectra were acquired in profile mode by 
the FT analyzer in a scan range of 100-1200 m/z, using AGC scan target 5 x 
105 and resolution 30000 FWHM at 400 m/z. Tandem mass spectra were 
acquired by the linear ion trap (LTQ) which was set up to fragment the 3 most 
intense ions exceeding 1 x 104 counts. Mass acquisition settings were: 
centroid mode, AGC scan target 5 x 104, precursor ion isolation width of 3 m/z, 
and collision energy (CID) of 35 eV. Dynamic exclusion was enabled to reduce 
redundant spectra acquisition: 2 repeat counts, 20 sec repeat duration, 30 sec 
of exclusion duration. Moreover, only singly and unassigned charged ions 
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were fragmented. Instrument control and spectra analysis were provided by 
the software Xcalibur 2.0.7 and Chromeleon Xpress 6.80.  
2.7 On target and off target analyses of cranberry components and 
metabolites in human urine 
An in-house database was created for the on target analysis by adding all the 
cranberry extract components characterized as well as known cranberry 
metabolites identified in other studies and cranberry components deriving 
from other cranberry sources even if not present in the extract under 
investigation, in order to have a bigger dataset. The identification was carried 
out on the QualBrowser tool of Xcalibur 2.0.7 by using the exact mass and the 
isotopic and fragmentation patterns. 
The off target analysis consisted of searching for all the ions present in the 
urine samples collected after the cranberry assumption that were not present 
or present at intensity relative to noise (< 5*102) in the pre-treatment sample. 
The research was carried out on the QualBrowser tool of Xcalibur 2.0.7 by 
screening the full MS spectra acquired in negative ion mode in ranges of 5 
m/z and 10 minutes for each sample. Each ion detected with those filters was 
exported with the relative MS/MS spectrum, if present. The identification was 
performed by following two different approaches based on the exact mass and 
isotopic and fragmentation patterns. The first approach consists of giving the 
precursor ion and the MS/MS spectrum list as inputs in the Compound 
Identification tool of CFM-ID (http://cfmid.wishartlab.com/identify), using as 
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mass tolerance error 5 ppm for the precursor ion and 0.3 Da for the fragments. 
CFM-ID searches for candidates in available databases (HMDB and KEGG) 
based on the exact mass, then generating in-silico MS/MS spectra of all the 
candidates and then comparing the experimental data with those obtained in-
silico. The top candidates were ranked (Jaccard Score) according to how 
closely they matched and returned to a list. The second approach was initially 
focused on the calculation of the elemental composition performed on the 
Elemental Composition page of Xcalibur 2.0.7 by using the following 
parameters: mass tolerance 5 ppm, charge -1, no use of Nitrogen Rule, C H 
O N P S as elements in use. The top 5 formulae were searched in PubChem 
in order to obtain a list of candidates. Next, the Peak Assignment tool of CFM-
ID was used to predict the MS/MS spectra of the putative identified 
compounds and compare the in-silico spectra obtained with the experimental 
spectra. 
2.8 Candida albicans adhesion ex-vivo assay 
C. albicans biofilm-forming ability was evaluated on polystyrene 96-well plates 
using the reference strain C. albicans SC5413 [24]. Prior to experiments, C. 
albicans was grown overnight in yeast extract, peptone, dextrose (1% w/v 
yeast extract, 2% w/v peptone, 2% w/v dextrose) liquid medium (YPD) at 30°C 
in an orbital shaker. Cells were then washed with cold phosphate-buffered 
saline (PBS). A standard inoculum of 5 x 105 cells/mL was prepared in Roswell 
Park Memorial Institute 1640 medium (RPMI – 1640) and added or not with 
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urine fractions as well as Anthocran™ 0.1 mg/mL. 100 µL/well of the inoculum 
was firstly incubated at 37°C for 1 hour to promote adhesion. Non-adherent 
cells were removed and wells washed with PBS; medium was replaced and 
the plate further incubated for 24 hours. Biofilm-forming ability was quantified 
by crystal violet (CV) staining for total biomass measurement. Two 
independent experiments were carried out with six replicates for each 
condition. Urine samples were lyophilized, reconstituted in RPMI – 1640 and 
diluted 1:2 in the same medium. 
 
 
3. Results 
3.1 Characterization of Anthocran™ components 
Polyphenols classes of the cranberry extract were characterized by HPLC-UV 
analysis at typical wavelength: 310 nm for phenolic acids, 365 nm for 
flavonols, 520 nm for anthocyanins, 278 nm for benzoic acids, flavanols and 
PACs (Figure 1). The identification of each compound in the extract was then 
obtained on the basis of the exact mass and of the isotopic and the 
fragmentation patterns, by acquiring the mass spectra in positive and in 
negative ion mode. All compounds identified are reported in Table 1, Table 2 
and Table 3. 
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Figure 1 - Characterization of cranberry extract constituents by HPLC-UV : 
A) phenolic acids, 310 nm ; B) flavonols, 365 nm ; C) anthocyanins, 320 nm ; 
D) benzoic acids, flavanols and PACs, 278 nm. 
  
 
 
 
 
 
 
 
Positive ion mode  Name RT (min) [M]+ Fragments 
 Anthocyanins 
 
Cyanidin 19 287.05556 259+255+251+245+242+125 
 
Peonidin 24 301.07121 268+258+230+177+151 
 
Cyanidin-3-O-arabinoside 6.2 419.09782 287 
 
Peonidin-3-O-arabinoside 10 433.11347 301 
 
Cyanidin-3-O-galactoside 4.15 449.10838 287 
 
Cyanidin-3-O-glucoside 4.6 449.10838 287 
 
Petunidin-3-O-arabinoside 5 449.10838 317 
 
Peonidin-3-O-galactoside 7.3 463.12403 301 
 
Peonidin 3-O-glucoside 7.6 463.12403 301 
 Malvidin-3-O-galactoside 8 493.13460 331 
  Malvidin-3-O-glucoside 8.4 493.13460 331 
Table 1 – Anthocyanins composition in Cranberry extract 
  
 
 
 
 
 
 
 
 
Negative ion mode Name RT (min) m/z Fragments 
 Phenolic and benzoic acids 
 
Benzoic acid 8.3 121.02896 77 
 
Protocatechuic acid 4 153.01879 109 
 
p-Coumaric acid 13.6 163.03952 119 
 
Gallic acid 2.5 169.01370 125 
 
Caffeic acid 7.9 179.03444 135 
 
Ferulic acid 4.9 193.05009 149+134 
 
Sinapinic acid 6.2 223.06065 179+164+149+135 
 
Caffeoyl glucose 5 341.08726 179+135 
  Chlorogenic acid 6 353.08727 191+179+161 
Table 2 – Phenolic and benzoic acids in Cranberry extract 
  
 
 
Positive and 
negative ion mode 
Name 
RT 
(min) 
[M+H]+ Fragments [M-H]- Fragments 
 Flavonols, Flavanols, PACs 
  Coumarin 14 147.04460 119+91 145.02896 - 
  Scopoletin 17.8 193.05008 165+152+133+119+105 191.03444 - 
  Kaempferol 55 287.05556 
259+251+241+231+ 
213+165+ 153+137+121 
285.03992 - 
  Epicatechin 5.7 291.08685 
169+165+151+147+139+
123 
289.07121 
245+205+179+161+ 
151+ 137+125+109 
  Catechin 9 291.08686 
169+165+151+147+139+
123 
289.07122 
245+205+179+161+ 
151+ 137+125+109 
  Quercetin 48.5 303.05047 
257+247+229+165+ 
153+ 149+ 137+121 
301.03483 
273+257+229+179+ 
151+ 121+107 
  Epigallocatechin 4.4 307.08177 - 305.06613 
261+221+219+179+ 
137+125 
  Gallocatechin 3.1 307.08177 - 305.06613 
261+221+219+179+ 
137+125 
  Isorhamnetin 55.8 317.06612 
299+285+281+274+ 
257+ 165+ 153+139 
315.05048 
287+271+259+243+ 
203+163+151 
  Myricetin 32 319.04539 
290+273+255+245+ 
165+ 153+ 137 
317.02975 
255+227+193+179+ 
151+137+107 
  
3'-O-
methylmyricetin 
50 333.06104 
301+287+277+273+ 
245+193+165+153+ 139 
331.04540 
287+271+263+179+ 
151 
  Syringetin 55.8 347.07669 
315+291+287+269+ 
181+165+153+139 
345.06104 315 
 
 
  
 
 
Positive and 
negative ion mode 
Name 
RT 
(min) 
[M+H]+ Fragments [M-H]- Fragments 
  Flavonols, Flavanols, PACs 
  Quercetin-3-O-arabinofuranoside 25.2 435.0927 303 433.0771 301 
  Quercetin-3-O-arabinopyranoside 28.4 435.0927 303 433.0771 301 
  Quercetin-3-O-xylopyranoside 26.6 435.0927 303 433.0771 301 
  Catechin-3-O-gallate 16.6 443.0978 291+273+151+139 441.0822 
315+297+289+ 
161+ 153 
  Epicatechin-3-O-gallate 20 443.0978 291+273+151+139 441.0822 
330+305+289+ 
161+ 139 
  Kaempferol-7-O-glucoside 27.2 449.1084 287 447.0927 284 
  
Isorhamnetin-3-O-
arabinofuranoside 
37 449.1084 317 447.0927 314 
  Isorhamnetin-3-O-xylopyranoside 38,5 449,10838 317 447,09274 314 
  
Isorhamnetin-3-O-
arabinopyranoside 
41 449,10838 317 447,09274 314 
  Quercetin-3-O-rhamnoside 30,5 449,10839 303 447,09275 301 
  Myricetin-3-O-arabinofuranoside 16,6 451,08765 319 449,07201 317 
  Myricetin-3-O-arabinopyranoside 19,6 451,08765 319 449,07201 317 
  Myricetin-3-O-xylopyranoside 19 451,08765 319 449,07201 317 
 
  
 
Positive and 
negative ion mode 
Name RT (min) [M+H]+ Fragments [M-H]- Fragments 
  Flavonols, Flavanols, PACs 
 Quercetin 3-O-glucoside 22,4 465,10329 303 463,08765 301 
 Quercetin-3-O-galactoside 21,5 465,10330 303 463,08766 301 
 Isorhamnetin-3-O-
glucopyranoside 
34,5 479,11894 317 477,10330 315 
 Isorhamnetin-3-O-
glucofuranoside 
32,8 479,11894 317 477,10330 315 
 Isorhamnetin-3-O-galactoside 31,1 479,11894 317 477,10330 315 
 Syringetin-3-O-
arabinofuranoside 
38,8 479,11894 347 477,10330 345 
 Syringetin-3-O-xylopyranoside 39,8 479,11894 347 477,10330 345 
 Syringetin-3-O-
arabinopyranoside 
43,5 479,11894 347 477,10330 345 
 Myricetin-3-O-glucoside 15,1 481,09820 319 479,08256 317 
 Myricetin-3-O-galactoside 14,5 481,09821 319 479,08257 317 
 Syringetin-3-O-rhamnoside 43,8 493,13460 347 491,11896 - 
 Proanthocyanidin A-type 
dimer 
17/23 577,13457 
437+425+397+ 
287 
575,11893 425+289+287 
  
Proanthocyanidin B-type 
dimer 
22,6 579,15022 
453+439+427+ 
409+301+291 
577,13458 425+407+289 
 
Proanthocyanidin A-type 
trimer 
16/25 /27.3 865,19796 
713+577+425+ 
287 
863,18232 575+423+289 
  
Proanthocyanidin B-type 
trimer 
11.5/ 14.3/ 
24 
867,21361 
579+427+409+ 
291 
865,19797 
577+425+407+ 
287 
Table 3 – Flavonols, Flavonols and PACs in Cranberry extract
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3.2 On target analysis of human urine after cranberry extract intake 
The on target analysis was based on the use of the database reported in the 
Table S1 of Supplementary materials, composed of the cranberry extract 
components characterized and by cranberry compounds and metabolites 
characterized in other studies [15, 16, 19, 20, 25-28]. The identification was 
performed on Xcalibur 2.0.7 by using the exact mass, the isotopic and 
fragmentation patterns and the retention time. The last feature was only used 
for cranberry extract components, thus permitting the identification of 
compounds not intense enough to be fragmented, such as gallic acid, 
kaempferol, quercetin, isorhamnetin, syringetin, quercetin-3-O-
arabinofuranoside, isorhamnetin-3-o-arabinopyranoside, quercetin 3-O-
rhamnoside and quercetin-3-O-galactoside. The fragmentation pattern 
however was fundamental for the identification of the metabolites described 
in other studies as well as for the confirmation of the identity of some cranberry 
components. In Figure 2 are reported the single ion chromatograms and the 
MS/MS spectra of some identified compounds : Figure 2A showed the 
chromatograms of protocatechuic acid (4.1 min), 2,5-dihydroxybenzoic acid 
(6.9 min), 2,4-dihydroxybenzoic acid (8.6 min) and 2,3-dihydroxybenzoic acid 
(9.3 min) and their MS/MS spectrum which is characterized by the 109 m/z 
fragment deriving from the loss of CO2 ; Figure 2B showed the chromatogram 
and the MS/MS spectrum of p-coumaric acid, which give 119 m/z as fragment 
ion that derives from the loss of CO2 ; in Figure 2C are reported sinapinic acid  
chromatogram and MS/MS spectrum, which is characterized by the fragment 
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deriving from the loss of CO2  (179 m/z) and those from the loss of the two 
methyl groups (164 m/z and 149 m/z) ; Figure 2D showed the chromatogram 
and the MS/MS spectrum of hippuric acid, which give 134 m/z as fragment ion 
that derives from the loss of CO2 ; in Figure 2E are reported the 
chromatograms of two isomers (3.7 and 4.5 min) of hydroxyhippuric acid and 
the MS/MS spectrum, which is characterized by the fragment deriving from 
the loss of CO2  (150 m/z) and that at 100 m/z which comes from the 
fragmentation of the aromatic ring . The identification was mainly carried out 
using the negative ion mode : in Table 4 are reported all the compounds and 
metabolites identified with the m/z, RT and fragments where available.  
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Figure 2 – Single ion chromatograms and MS/MS spectra of some cranberry 
components and metabolites identified using the on target analysis :  A) 
Dihydroxybenzoic acids ; B) p-Coumaric acid ; C) Sinapinic acid ; D) Hippuric 
acid ; E) Hydroxyhippuric acid isomers 1 and 2. 
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Name [M-H]- RT MS/MS Fragments 
Cranberry extract components    
 Protocatechuic acid 153.01879 4.1 109 
 p-Coumaric acid 163.03952 13.8 119 
 Gallic acid 169.01370 2.5 - 
 Sinapinic acid 223.06065 6.3 179+164+135 
 Kaempferol 285.03992 55 - 
 Quercetin 301.03483 48.5 - 
 Isorhamnetin 315.05048 55.8 - 
 Syringetin 345.06104 55.8 - 
 Quercetin-3-O-arabinofuranoside 433.07709 25.2 - 
 Isorhamnetin-3-o-arabinopyranoside 447.09274 41 - 
 Quercetin 3-O-rhamnoside 447.09275 30.5 - 
  Quercetin-3-O-galactoside  463.08766 21.5 - 
Cranberry metabolites characterized 
in other studies    
 2-Hydroxybenzoic acid 137.02387 6.6 93 
 Cinnamic acid 147.04461 14.6 103 
 2,3-dihydroxybenzoic acid 153.01879 9.3 109 
 2,5-dihydroxybenzoic acid 153.01879 6.9 109 
 2,4-dihydroxybenzoic acid 153.01879 8.6 109 
 3-(4-hydroxyphenyl)-propionic acid 165.05516 14.8 147+121+103 
 Vanillic acid 167.03444 8.5 123+108 
 3,4-Dihydroxyphenylacetic acid 167.03444 3.5 123 
 Hippuric acid 178.05042 8 134 
 3,4-Dihydroxyhydrocinnamic acid 181.04991 5.1 121 
 Hydroxyhippuric acid isomer 1 194.04562 3.7 150+100+93 
  Hydroxyhippuric acid isomer 2 194.04562 4.5 150+100+93 
Table 4 – Cranberry components and metabolites identified using the on target 
analysis 
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3.3 Off target analysis of human urine after cranberry extract intake 
The metabolites identified through the off target analysis are reported in Table 
5. In Figure 3 are reported, as examples, the single ion chromatograms of 
quinic acid (Figure 3B) and 5’-(3’,4’-dihydroxyphenyl)-gamma-valerolactone 
(Figure 3E) in the urine fraction in which they reached their maximum 
concentration (1 h for quinic acid and 12 h for 5’-(3’,4’-dihydroxyphenyl)-
gamma-valerolactone), while in the control sample (Figure 3A and Figure 3D 
respectively) they were not present. The analysis was performed using the 
negative ion mode because all the compounds identified using the on target 
analysis were mainly detected in this polarity mode. As the interesting 
compounds were those whose identification can be hypothesized, other 
unidentified compounds, or those recognized as coming from the human basal 
metabolism (e.g. aminoacids), were not included on the list. In Figure 3C and 
Figure 3F are reported the experimental MS/MS spectra used as input for the 
Compound Identification tool of CFM-ID that gave as best matched results 
quinic acid and 5’-(3’,4’-dihydroxyphenyl)-gamma-valerolactone respectively : 
quinic acid MS/MS spectrum is characterized by the ions 145, 129 and 101 
m/z and 5’-(3’,4’-dihydroxyphenyl)-gamma-valerolactone MS/MS spectrum is 
composed by the ions 163 and 122 m/z. The structures reported for each 
fragment ion were predicted by the software. 
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Figure 3 – The peak of quinic acid (A) and 5’-(3’,4’-hydroxyphenyl)-gamma-valerolactone (D) 
in the control sample were not present. Single ion chromatogram of quinic acid (B) in the urine 
sample at 1 h and 5’-(3’,4’-hydroxyphenyl)-gamma-valerolactone (E) in the urine sample at 12 
h. MS/MS spectra of quinic acid (C) and 5’-(3’,4’-hydroxyphenyl)-gamma-valerolactone (F) with 
the predicted structure for each fragments assigned by the Compound Identification tool of 
CFM-ID . 
  
 
m/z MS/MS Fragments Formula Delta ppm Name Database 
181.04991 121 C9H10O4 -3.989 3,4-Dihydroxyhydrocinnamic acid HMDB 
191.05536 145+129+101 C7H12O6 -3.934 Quinic acid HMDB 
192.06700 157+131+111+74 C10H11NO3 1.996 2-Methylhippuric acid HMDB 
194.04562 150+100+93 C9H9NO4 -1.346 (4-)Hydroxyhippuric acid HMDB 
194.04562 150+100+93 C9H9NO4 -1.346 (2-)Hydroxyhippuric acid HMDB 
207.0657 163+122 C11H12O4 -2.812 5-(3' ,4' -dihydroxyphenyl)-gamma-valerolactone HMDB 
223.0606 193+179+164+149 C11H12O5 -2.587 Sinapinic acid HMDB 
285.0406 
252+241+223+205+199 
+175+163+151 
C15H10O6 0.451 2'-Hydroxygenistein HMDB 
287.0225 207+163 C11H12SO7 -2.084 
5-(4' -hydroxyphenyl) -gamma-valerolactone-3' -O-
sulphate 
HMDB 
287.0225 207+163 C11H12SO7 -2.084 
5-(3' -hydroxyphenyl) - gamma-valerolactone-4' -O-
sulphate 
HMDB 
303.018 259+223+179 C11H12SO8 0.090 
5-(3',4',5'-Trihydroxyphenyl) -gamma-valerolactone-3'-
O-sulphate 
HMDB 
305.0339 225+208+179+162 C11H14SO8 0.909 4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate HMDB 
370.0783 
325+194+166+138+ 
123+113 
C15H17NO10 1.001 Salicyluric glucuronide CFM-ID 
383.0445 
303+285+259+244+ 
217+153+137+123 
C16H16SO9 0.790 3-O-Methylcatechin-sulphate CFM-ID 
Table 5 – Metabolites identified using the off target analysis
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3.4 Ex-vivo inhibition of Candida albicans adhesion by urine fractions 
Anthocran™ 0.1 mg/mL, urine before Anthocran™ intake and urine fractions 
(1h, 2h, 4h, 6h, 10h, 12h and 24h) collected after the treatment were tested to 
investigate the potential ability to reduce C. albicans adhesion on polystyrene 
96-well plates. The results are reported in Figure 4. Urine samples before the 
treatment were shown to be inactive, while it is evident that Anthocran™ was 
able to strongly reduce adhesion and biofilm formation (p < 0.001). 
Considering urine after Anthocran™ assumption, two fractions were shown to 
significantly reduce the adhesion  
 
compared to the control (p < 0.001) : 1 hours and 12 hours after the last 
capsule intake. A lower activity was observed for the 2 hours and 10 hours 
fractions compared to the control (p < 0.05). 
Figure 4 – Activity of Anthocran™ (0.1 mg/mL), urine before 
Anthocran™ intake and urinary fractions after the treatment. Significant 
differences are indicated by *p < 0.05, ***p < 0.001, Mann-Whitney test. 
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3.5 Possible bioactive components present in urine fractions 
The area under the curve of the selected ion chromatogram of each 
compound identified with the on target and off target approach were extracted 
and normalized to that of the internal standard (ethyl gallate) in order to obtain 
semiquantitative ratios of the compounds present in each urine fraction. A 
selection was then made by picking those metabolites which were present at 
their maximum relative concentration in the two most active urine fractions (1 
h and 12 h after the last capsule intake). As examples, in Figure 5 are shown 
two compounds which reached the maximum relative abundance in the active 
fractions and two compounds that reached it in other urine fractions : Figure 
5A is relative to 5-(3' -hydroxyphenyl)- gamma-valerolactone-4' -O-sulphate, 
which Tmax was 1 h ;  in Figure 5B shows the excretion profile of quercetin, 
which Tmax was 12 h ; Figure 5C is relative p-coumaric acid, which Tmax was 
2 h ;  in Figure 5D shows the excretion profile of 3-O-methylcatechin sulphate, 
which Tmax was 4 h.  The list of the possible bioactive components contains 
both cranberry components and metabolites (Table 6). 
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Figure 5 – Excretion profiles of 5-(3' -hydroxyphenyl)- gamma-valerolactone-4' -O-
sulphate (A), quercetin (B), p-coumaric acid (C) and 3-O-methylcatechin sulphate (D) 
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NAME TMAX 
IDENTIFICATION 
APPROACH 
2-Hydroxybenzoic 1h On Target 
Cinnamic acid 1h On Target 
2,3-Dihydroxybenzoic acid 1h On Target 
Hydroxyhippuric acid isomer 1 1h On Target/Off Target 
Hydroxyhippuric acid isomer 2 1h On Target/Off Target 
2,5-Dihydroxybenzoic acid 1h On Target 
3,4-Dihydroxyphenylacetic acid 1h On Target/Off Target 
Kaempferol 12h On Target 
Quercetin 12h On Target 
Isorhamnetin 12h On Target 
Syringetin 12h On Target 
Quinic acid 1h Off Target 
2'-Hydroxygenistein 1h Off Target 
4-Hydroxy-5-(dihydroxyphenyl)-valeric 
acid-O-sulphate 
1h Off Target 
Salyciluric glucuronide 1h Off Target 
5-(3' -hydroxyphenyl)- gamma-
valerolactone-4' -O-sulphate 
1h Off Target 
5-(3' ,4' -dihydroxyphenyl)-gamma-
valerolactone 
12h Off Target 
Table 6 – Cranberry components and metabolites that have the highest relative 
content in the active urine fractions. 
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4. Discussion 
4.1 Compounds identified using the on target analysis 
The on target analysis allowed the identification of several cranberry 
components already present in the extract as well as some known 
metabolites. The results reported are based on the acquisition in negative ion 
mode, since the positive mode didn’t show more information. In fact, 
anthocyanins, which are the main components well ionized in positive 
acquisition mode, were not detected at all. The reason of their absence in 
urine could be that they have low bioavailability, but also because they can be 
catabolised by the colonic microflora into small phenolic compounds, such as 
protocatechuic acid, phloroglucinaldehyde, ferulic acid, syringic acid, gallic 
acid and vanillic acid [29-31]. In the present study we detected protocatechuic 
acid, ferulic acid, gallic acid and vanillic acid.  Some flavonols were found as 
well as some of their glicosilated forms : kaempferol, quercetin and traces of 
its glicosides (quercetin-3-O-arabinofuranoside, quercetin 3-O-rhamnoside 
and quercetin-3-O-galactoside), syringetin and isorhamnetin with traces of 
isorhamnetin-3-O-arabinopyranoside. The low abundance of the glicosilated 
forms is due to the enzymatic hydrolysis by cellular and bacterial β-
glucosidases in the intestine into the relative aglycones [32]. The aglycones 
can undergo phase-II metabolism or methylation and they can be transformed 
by microbiota in the intestinal tract into phenolic acids by C-ring cleavage [33]. 
Studies performed on quercetin (the most representative flavonol) and related 
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glicoside metabolisms in the intestine showed that the main metabolites are 
represented by hydroxyphenylacetic acid catabolites [34, 35]. Having 
performed β-glucuronidase hydrolysis, we were able to detect the aglycon of 
quercetin, kaempferol, syringetin and isorhamnetin as free form. The last one 
can derive from the isorhamnetin derivatives present in the extract or from the 
methylation of quercetin. Moreover, 3,4-dihydroxyphenylacetic acid was found 
in urine as possible metabolite of flavonols deriving from intestinal microbiota 
metabolism. Proanthocyanidins present in the extract (procyanidins A-type 
and B-type) were not detected in urine in the present study. Controversial 
results have been obtained on this class of polyphenols in previous studies, 
in particular concerning procyanidin A2 to which several studies attributed the 
activity of cranberry products in UTIs prevention. In most cases they weren’t 
found in human urine [15-18] as in our study. By contrast, two works reported 
PACs in human urine : one work was performed on men and postmenopausal 
women of 50–70 years who assumed a single dose of 237 mL of cranberry 
juice (PACs content in the juice was not reported) [19]; in the second study, 
performed by the same research group, five young women (20-30 years) 
consumed 237 mL/day of cranberry juice (140 mg of PACs) according to a 
weekly schedule for 7 weeks  [20]. The results that they obtained were very 
low levels of PAC-A2 quantified in human urine (Cmax = 24 ng/mg creatinine) 
and they concluded that PAC-A2 cannot be used as biomarker of cranberry 
intake since there was not correlation with the amount of juice consumed. 
Taking into consideration all these results, it is commonly accepted that PACs 
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have a very low bioavailability, which decreases as the degree of their 
polymerization increases [27]. Moreover, it is reported that human microbiota 
degrades PACs in the colon into phenolic compounds : phenylacetic acids and 
phenylpropionic acids as metabolites of procyanidins A2, B2, catechin and 
epicatechin ; for procyanidin B2, catechin and epicatechin also valerolactones 
and valeric acids derivatives [36, 37]. In the present study, we detected 3,4-
dihydroxyphenylacetic acid and 3-(4-hydroxyphenyl)-propionic acid, but also 
dihydroxybenzoic acids, hydroxybenzoic acid and hydroxyhippuric acids 
which are metabolites deriving from phenylpropionic acids [38]. The main 
class of polyphenols identified was the one of phenolic acids : protocatechuic 
acid, p-coumaric acid, gallic acid and sinapinic acid were already found in the 
extract, but they can also derive from the metabolism of other polyphenols as 
mentioned above ; 3,4-dihydroxyhydrocinnamic acid and cinnamic acid 
probably derived from the metabolism of chlorogenic acid [16], while 
hydroxybenzoic acid, dihydroxybenzoic acids, hippuric acid and 
hydroxyhippuric acids can derived from the metabolism of all the other 
flavonoid components [38].  
 
4.2 Compounds identified using the off target analysis 
In the off target analysis several metabolites were identified. Some of them 
had already been identified using the on target analysis, confirming the 
reliability of this second approach. Figure 6 shows an overview of all the 
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compounds which have been identified in the present study with the on target 
(red circle) and off target (blue circle) analyses.  
 
 
Compounds already identified were : 3,4-dihydroxyhydrocinnamic acid, 
sinapinic acid and the two hydroxyhippuric acid isomers, which were 
annotated by CFM-ID as 4- and 2-hydroxyhippuric acids. However standards 
will be used to confirm the correct identities of this two isomers. Most of the 
other compounds were putatively identified with CFM-ID as the best match 
(given by the highest Jaccard score), but the identities of the top 5 candidates 
were manually verified in order to give an annotation that could also have a 
biological meaning. Two acids were identified : quinic acid, which can derive 
from chlorogenic acid, and 2-methylhippuric acid, a methyl derivative of 
hippuric acid. 2'-hydroxygenistein was found as first candidate for the ion 
285.0406 m/z, but it cannot derive from cranberry intake since it is not present 
Figure 6 – Venn diagram reporting all the compounds identified with the on target 
(red circle) and off target (blue circle) analyses. 
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in the extract and cannot be a product of metabolism. Other possible 
candidates returned by CFM-ID are other isoflavones (3'-Hydroxygenistein), 
some aurones (Cernuine, Maritimetin), one flavone (Luteolin) and one flavonol 
(Kaempferol, excluded because the retention time was different from that 
characterized in the extract), but none of them could derive from the extract 
or from the metabolism of extract components. In this case to obtain an 
identification, further studies are needed (e.g. the use of standard). Different 
valerolactones and one valeric acid derivative were identified : 5-(3' ,4' -
dihydroxyphenyl)-gamma-valerolactone, 5-(4' -hydroxyphenyl) -gamma-
valerolactone-3'-O-sulphate, 5-(3' -hydroxyphenyl) - gamma-valerolactone-4' 
-O-sulphate, 5-(3',4',5'-Trihydroxyphenyl) -gamma-valerolactone-3'-O-
sulphate, 4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate. Among 
those metabolites, 5-(3' -hydroxyphenyl) - gamma-valerolactone-4' -O-
sulphate had been identified in previous studies [16, 18] and it was not 
included in the database used for the on target research because of the 
sulphate conjugation (not considered because of the β-glucuronidase 
hydrolysis, which also has sulphatase activity). In a very recent study, which 
reported other valerolactone derivatives, also 5-(3' ,4' -dihydroxyphenyl)-
gamma-valerolactone was detected [39]. None of the other valerolactones 
here described were previously identified in urine after cranberry intake, but 
they are known to be PACs metabolites [37]. All the metabolites reported thus 
far were identified with the first approach of the off target analysis. While 
salicyluric glucuronide and 3-O-methylcatechin-sulphate were identified with 
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the second approach, which was itself shown to be less precise because it 
doesn’t give a similarity score but it verified only the presence of overlapping 
fragments, so further investigation is needed. Since all these compounds have 
been identified by using the exact mass and the isotopic and the fragmentation 
pattern in comparison with in silico MS/MS spectra, a higher level of 
identification could be obtained by using standards of those components, so 
that the retention time can be used to confirm the identity. The results of all 
the studies performed on metabolites characterization in human urine after 
cranberry intake are reported in Table 7 and compared to that obtained in the 
present study. As already discussed above, PACs were detected only in two 
studies [19, 20] but one of such [19] didn’t report the amount of PACs in the 
cranberry product. Moreover, PACs metabolites described were only phenolic 
acids and no valerolactone derivatives were detected. The study performed 
by Valentova et al. [15] didn’t report in details all the compounds identified, but 
no valerolactones were present. All the other studies [16-18, 39] were based 
on a single-dose treatment constituted by a high content of PACs. Feliciano 
et al. [16,18] were able to identify a huge number of metabolites by using 
standards, but they detected only one valerolactone derivative. Peron et al. 
[39] identified a lower amount of metabolites but a higher number of 
valerolactone derivatives, two of which were detected also in our study. 
 
 
 
 
 
Table 7 – Results of known studies on metabolite characterization after cranberry products intake. The comparison regards: cranberry treatment,  
PACs content in the cranberry product used, the time of the treatment, the number of cranberry metabolites identidfied, the eventual presence of 
PACs and the number of known PACs metabolites including phenolic acid and valerolactone derivatives.
 PRESENT 
STUDY 
VALENTO
VA ET AL. 
[15] 
MCKAY 
ET AL. 
[19] 
WALSH ET 
AL. [20] 
ISWALDI ET 
AL [17] 
FELICIANO 
ET AL. 
[16,18] 
PERON ET 
AL. [39] 
CRANBERRY 
TREATMENT 
2 
capsules/d
ay 
standardize
d cranberry 
extract 
1200 
mg/day of 
dried 
cranberry 
juice 
237 mL 
cranberry 
juice 
cocktail 
237 mL/day 
cranberry 
juice cocktail 
0.6 mL/kg of 
cranberry 
syrup 
450 mL of a 
single-
strength 
cranberry 
juice 
beverage 
360 mg of 
cranberry 
extract 
PACS CONTENT 
36 
mg/capsule 
14.4 mg NA 140 mg 0.71% (w/v) 710 mg 
42.6% w/w of 
PAC-A/14.6% 
w/w of PAC-B 
TREATMENT TIME 7 days 8 weeks 
Single 
dose 
(24h) 
7 weeks 
Single dose 
(24h) 
Single dose 
(24h) 
Single dose 
(24h) 
NUMBER OF 
METABOLITES 
35 NA 26 19 32 57 14 
PACS PRESENCE no no yes yes no no no 
N PACS 
METABOLITES (N 
VALEROLACTONES) 
14 (5) NA 8 (0) 7 (0) 3 (0) 17 (1) 12 (6) 
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4.3 Reduction of C. albicans adhesion and biomass production by urine 
fractions and putative bioactive components of the active fractions 
The antiadhesive properties of cranberry, both in vitro and in vivo, have long 
been reported [40-43] mainly with regard to E. coli, which is the principal 
uropathogen that causes UTIs. An in vitro study showed that cranberry PACs 
prevent C. albicans biofilm formation in artificial urine [44]. In the present work 
we demonstrate for the first time that cranberry extract as well as some urine 
fractions after one week of cranberry treatment are able not only to reduce C. 
albicans adhesion but also its biomass production. Since the assay showed 
that fractions at 1 hour and 12 hours after the last capsule assumption were 
the most active, we focused attention on the components which reached their 
highest concentration in these fractions. The fraction at 1 hour contains mainly 
phenolic acids all deriving from the metabolism of cranberry polyphenols 
(identified with the on target analysis), but also one valerolactone and one 
valeric acid deriving from PACs metabolism. Among the phenolic acids 
selected, 3,4-dihydroxyphenylacetic acid was previously reported to have 
anti-adhesive activity, in an in vitro assay, against E. coli [45]. Moreover, a 
recent in vitro study [46] demonstrates that valerolactones derivatives have 
anti-adhesive activity against E. coli, confirming that the activity in vivo is not 
due to intact PACs but to their metabolites. The components found with the 
highest concentration in the 12 hours urine fraction are kaempferol, quercetin, 
syringetin, isorhamnetin and 5-(3' ,4' -dihydroxyphenyl)-gamma-
IV – Study 1 
 
99 
 
 
valerolactone. Considering the flavonol aglycones, they probably all derived 
from β-glucuronidase hydrolysis of the respective glucuronides or sulphates, 
but among those phenolics only quercetin was reported to have in vitro anti-
adhesive properties [47]. However, the in vitro activity reported for these 
compounds is related to E. coli, so we cannot exclude all the others putative 
bioactive components. 
 
5. Conclusions 
The HR-MS method developed allowed the identification of several cranberry 
components and metabolites in human urine after a standardized cranberry 
extract assumption. PACs were not detected as reported by previous studies, 
but several metabolites deriving from their catabolism operated by the gut 
microflora and hereto not found in vivo were identified. The crude extract and 
these two urine fractions collected after cranberry intake were found to be 
active against C. albicans adhesion ex-vivo. Among the metabolites that 
reached their highest concentration in these fractions there are also two 
known metabolites of PACs, 4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-
sulphate and 5-(3' -hydroxyphenyl)- gamma-valerolactone-4' -O-sulphate. To 
our knowledge this is the first work which demonstrates an ex-vivo inhibition 
of C. albicans adhesion by human urine after cranberry intake. We are now 
working on understanding whether the activity is related to one or more 
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components or to a synergy of such. Moreover the study will be performed on 
a huge number of subjects in order to evaluate the inter-individual variability. 
Abbreviations: UTIs, urinary tract infections; PACs, proanthocyanidins; 
CFM-ID, competitive fragmentation modeling for metabolite identification. 
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Table S1 – Database used for the on target analysis 
Name [M]+ Source 
Cyanidin 287.05556 Cranberry extract 
Peonidin 301.07121 Cranberry extract 
Pelargonidin-3-O-arabinoside 403.10290 [28] 
Cyanidin-3-O-arabinoside 419.09782 Cranberry extract 
Peonidin-3-O-arabinoside 433.11347 Cranberry extract 
Pelargonidin-3-O-galactoside 433.11347 [28] 
Delphinidin-3-O-arabinoside 435.09273 [15,28] 
Cyanidin-3-O-galactoside 449.10838 Cranberry extract 
Cyanidin-3-O-glucoside 449.10838 Cranberry extract 
Petunidin-3-O-arabinoside 449.10838 Cranberry extract 
Peonidin-3-O-galactoside 463.12403 Cranberry extract 
Peonidin 3-O-glucoside 463.12403 Cranberry extract 
Malvidin-3-O-arabinoside 463.12403 [28] 
Petunidin-3-O-galactoside 479.11895 [28] 
Malvidin-3-O-galactoside 493.13460 Cranberry extract 
Malvidin-3-O-glucoside 493.13460 Cranberry extract 
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Name [M+H]+ [M-H]- Source 
Coumarin 147.0446 145.02896 Cranberry extract 
Scopoletin 193.05008 191.03444 Cranberry extract 
Methyl-scopoletin 208.07355 206.0579 [17] 
Apigenin 271.06064 269.04499 [15] 
Kaempferol 287.05556 285.03992 Cranberry extract 
Dihydrocatechin 288.06338 286.04773 [17] 
Epicatechin 291.08685 289.07121 Cranberry extract 
Catechin 291.08686 289.07122 Cranberry extract 
Quercetin 303.05047 301.03483 Cranberry extract 
Epigallocatechin 307.08177 305.06613 Cranberry extract 
Gallocatechin 307.08177 305.06613 Cranberry extract 
Methyl-quercetin 316.0583 314.04265 [17,29] 
Isorhamnetin 317.06612 315.05048 Cranberry extract 
Myricetin 319.04539 317.02975 Cranberry extract 
3'-O-methyl-myricetin 333.06104 331.0454 Cranberry extract 
Syringetin 347.07669 345.06104 Cranberry extract 
Quercetin-3-O-arabinofuranoside 435.09273 433.07709 Cranberry extract 
Quercetin-3-O-arabinopyranoside 435.09273 433.07709 Cranberry extract 
Quercetin-3-O-xylopyranoside 435.09273 433.07709 Cranberry extract 
Catechin-3-O-gallate 443.09782 441.08218 Cranberry extract 
Epicatechin-3-O-gallate 443.09782 441.08218 Cranberry extract 
Kaempferol-7-O-glucoside 449.10838 447.09274 Cranberry extract 
Isorhamnetin-3-O-arabinofuranoside 449.10838 447.09274 Cranberry extract 
Isorhamnetin-3-O-xylopyranoside 449.10838 447.09274 Cranberry extract 
Isorhamnetin-3-O-arabinopyranoside 449.10838 447.09274 Cranberry extract 
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Name [M+H]+ [M-H]- Source 
Quercetin-3-O-rhamnoside 449.10839 447.09275 Cranberry extract 
Myricetin-3-O-arabinofuranoside 451.08765 449.07201 Cranberry extract 
Myricetin-3-O-arabinopiranoside 451.08765 449.07201 Cranberry extract 
Myricetin-3-O-xylopyranoside 451.08765 449.07201 Cranberry extract 
Quercetin 3-O-glucoside 465.10329 463.08765 Cranberry extract 
Quercetin-3-O-galactoside 465.1033 463.08766 Cranberry extract 
Methoxyquercetin 3-O-galactoside 479.11894 477.10329 [17] 
Isorhamnetin-3-O-glucopyranoside 479.11894 477.1033 Cranberry extract 
Isorhamnetin-3-O-glucofuranoside 479.11894 477.1033 Cranberry extract 
Isorhamnetin-3-O-galactoside 479.11894 477.1033 Cranberry extract 
Syringetin-3-O-arabinofuranoside 479.11894 477.1033 Cranberry extract 
Syringetin-3-O-xylopyranoside 479.11894 477.1033 Cranberry extract 
Syringetin-3-O-arabinopyranoside 479.11894 477.1033 Cranberry extract 
Myricetin-3-O-glucoside 481.0982 479.08256 Cranberry extract 
Myricetin-3-β-O-galactoside 481.09821 479.08257 Cranberry extract 
Methoxyquercetin-3-O-galactoside + OH 494.10603 492.09038 [17] 
Syringetin-3-O-rhamnoside 493.1346 491.11896 Cranberry extract 
Proanthocyanidin A-Type dimer 577.13457 575.11893 Cranberry extract 
Proanthocianidin B-Type dimer 579.15022 577.13458 Cranberry extract 
Proanthocyanidin A-Type trimer 865.19796 863.18232 Cranberry extract 
Proanthocyanidin B-Type trimer 867.21361 865.19797 Cranberry extract 
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Name [M-H]- Source 
Benzoic acid 121.02896 Cranberry extract 
4-Hydroxyibenzaldehyde 121.02895 [18] 
Phenylacetic acid 135.04460 [16,18] 
2-Hydroxybenzoic acid 137.02387 [16,18] 
3-Hydroxybenzoic acid 137.02387 [18-20] 
4-Hydroxybenzoic acid 137.02387 [18-20] 
Cinnamic acid 147.04461 [16,18] 
4-Hydroxyphenylacetic acid 153.03951 [18-20] 
Phloroglucinaldehyde 153.03879 [29] 
2,3-Dihydroxybenzoic acid 153.01879 [15] 
2,4-Dihydroxybenzoic acid 153.01879 [15] 
2,5-Dihydroxybenzoic acid 153.01879 [15] 
Protocatechuic acid 153.01879 Cranberry extract 
p-Coumaric acid 163.03952 Cranberry extract 
3-(4-hydroxyphenyl)-propionic acid 165.05516 [18] 
Vanillic acid 167.03444 [16,18-20] 
3,4-Dihydroxyphenylacetic acid 167.03444 [18-20] 
Gallic acid 169.01370 Cranberry extract 
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Name [M-H]- Source 
Hippuric acid 178.05042 [15,17] 
Caffeic acid 179.03444 Cranberry extract 
2-(4-hydroxyphenoxy)-propionic acid 181.05008 [16] 
Homovanillic acid 181.05008 [16,18-20] 
3,4-Dihydroxyhydrocinnamic acid (Dihydrocaffeic acid) 181.05008 Cranberry extract 
Ferulic acid 193.05009 Cranberry extract 
Citric acid 193.03482 [15] 
4-hydroxyhippuric acid 194.04533 [16,18] 
3-hydroxyhippuric acid 194.04533 [16,18] 
2-hydroxyhippuric acid 194.04533 [16,18-20] 
Dihydroferulic acid 195.06573 [16,18] 
Syringic acid 197.04550 [16,18] 
Sinapinic acid 223.06065 Cranberry extract 
Coumaroyl-hexose (Formic Acid Adduct) 325.09235 (371.09783) Cranberry extract 
Caffeoyl glucose –H2 339.07160 [17] 
Caffeoyl glucose  341.08726 Cranberry extract 
Chlorogenic acid 353.08727 Cranberry extract 
Sinapoyl-hexose 385.11348 Cranberry extract 
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Abstract 
The aim of the present investigation was to better understand the 
pharmacokinetic profile of bilberry (Vaccinium Myrtillus) anthocyanins and the 
role of glucose transporters (sGLT1 and GLUT2) on their absorption. In 
particular, the absorption of 15 different anthocyanins contained in a 
standardized bilberry extract (Mirtoselect®) was measured in rats by a 
validated LC-ESI-MS/MS approach. The plasma concentration peak (Cmax) 
of 11.1 ng/mL was reached after 30 minutes and fasting condition significantly 
increased the bioavailability of anthocyanins by more than 7 fold in respect to 
fed rats. Glucose co-administration did not interfere with the overall 
anthocyanin uptake. 
Bioavailability of each anthocyanin was then estimated by comparing the 
relative content in plasma vs extract. The 15 anthocyanins behaved differently 
in term of bioavailability and both the aglycone and the sugar moiety were 
found to affect the absorption. For instance, arabinoside moiety was 
detrimental while cyanidin enhanced bioavailability. Computational studies 
permitted to rationalize such results, highlighting the role of glucose 
transporters (sGLT1 and GLUT2) in anthocyanins absorption. In particular a 
significant correlation was found for the 15 anthocyanins between sGLT1 and 
GLUT2 recognition and absorption.  
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1. Introduction 
Anthocyanins (from Greek anthos = flower and kyanos = blue) are water-
soluble pigments, widely present in plants and belonging to the flavonoid 
class. They are responsible for the distinctive colours of plant tissues like blue, 
purple and red [1]. Their basic structure is composed of two aromatic rings (A 
and B) that are linked together by three carbon atoms forming a heterocycle 
with an oxygen atom (ring C). This basic structure, named anthocyanidin, is 
characterized by several hydroxyl groups to which are bound one or more 
sugar moieties, leading to a high number of possible compounds. The 
principal anthocyanidins present in nature are six, namely cyanidin (Cya), 
peonidin (Peo), petunidin (Pet), delphinidin (Del), malvidin (Mal) and 
pelargonidin (Pel). The glycosidic bond occurs mostly at C3 position but a 
second glycosylation frequently occurs on the C5 or C7: the sugars involved 
are mainly hexoses (glucose and galactose) or pentoses (arabinose, 
rhamnose and xylose) [2]. 
Several studies report the health benefits of anthocyanins, such as antioxidant 
[3], anti-inflammatory [4] and anticarcenogenic properties [5], leading to a 
potential use of these molecules in several oxidative-based diseases. 
Moreover, epidemiological evidence suggests that the consumption of 
anthocyanins decreases the risk of cardiovascular diseases, cancer growth 
and chronic degenerative diseases [6-8].  
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Bioavailability of anthocyanins was believed to be low [9], less than 2% [10], 
but then, using a stable isotopically labelled anthocyanin, it was found that it 
is comparable to that of other flavonoids; in particular bioavailability of 
cyanidin-3-glucoside was estimated to be at least 12 % [11]. Several studies 
have shown that anthocyanins are rapidly absorbed as such in the stomach 
and small intestine [12-15]. After ingestion, anthocyanins appear to permeate 
the stomach mucosa; proposed mechanisms include a bilitranslocase carrier 
and a saturable transporter, GLUT1 [16-18]. More recently, computational 
studies have shown at molecular level that anthocyanins can bind to glucose 
transporters such as GLUT1 thus underlining the importance of such a 
transporter for anthocyanin bioavailability [18]. However more studies are 
needed to study the role of gastric GLUT1 on anthocyanin absorption, also 
considering that little is known on the distribution of GLUT1 in the stomach 
tissue.  Nevertheless, the majority of absorption and transformation occurs in 
the small intestine where anthocyanins are hypothesized to undergo a glucose 
dependent absorption which is mediated by sGLT1 and GLUT2, the latter 
providing a basolateral exit [19]. An elegant in vitro confirmation of such an 
absorption mechanism has been reported by Zou et al [20] who by using 
human intestinal epithelial (Caco-2) cells have found that cyanidin-3-O-β-
glucoside absorption is dependent on the activities of sGLT1 and GLUT2. 
Based on these premises, the aim of the present investigation is to better 
understand the role of glucose transporters and in particular of sLGT1 and 
GLUT2 on anthocyanin absorption. To do this, the absorption of 15 different 
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anthocyanins contained in a standardized bilberry extract (Mirtoselect®, 36% 
anthocyanins, Indena) (Table 1) was measured by a validated LC-ESI-MS/MS 
approach; the role of sGLT1 and GLUT2 in modulating the yield of absorption 
of each anthocyanin was then investigated by docking studies which provided 
a better understanding of the molecular recognition of anthocyanins as well 
as the effects of sugar and the aglycone moieties. Finally, the effects of fasting 
and glucose co-ingestion on anthocyanin bioavailability was evaluated. 
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Table 1 – Anthocyanins contained in a standardized bilberry extract (Mirtoselect®) 
 
 
 
 
 
 
          
Anthocyanins R1 R2 Gly MW 
Cyanidin-3-O-arabinoside OH H Arabinose 419 
Peonidin-3-O-arabinoside OCH3 H Arabinose 433 
Delphinidin-3-O-arabinoside OH OH Arabinose 435 
Cyanidin-3-O-galactoside OH H Galactose 449 
Cyanidin-3-O-glucoside OH H Glucose 449 
Petunidin-3-O-arabinoside OCH3 OH Arabinose 449 
Peonidin-3-O-galactoside OCH3 H Galactose 463 
Peonidin-3-O-glucoside OCH3 H Glucose 463 
Malvidin-3-O-arabinoside OCH3 OCH3 Arabinose 463 
Delphinidin-3-O-galactoside OH OH Galactose 465 
Delphinidin-3-O-glucoside OH OH Glucose 465 
Petunidin-3-O-galactoside OCH3 OH Galactose 479 
Petunidin-3-O-glucoside OCH3 OH Glucose 479 
Malvidin-3-O-galactoside OCH3 OCH3 Galactose 493 
Malvidin-3-O-glucoside OCH3 OCH3 Glucose 493 
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2. Materials and Methods 
2.1 Reagents 
Formic acid, trichloroacetic acid (TCA) and LC–MS grade solvents were 
purchased from Sigma–Aldrich (Milan, Italy). LC-grade H2O (18 MΩ cm) was 
prepared with a Milli-Q H2O purification system (Millipore, Bedford, MA, USA). 
Naringenin-7-O-glucoside used as internal standard was from Extrasynthese 
(Genay, France). Standardized bilberry extract (V. Myrtillus) containing 36% 
anthocyanins (Mirtoselect®) was generously donated by Indena S. p. A (Milan, 
Italy). 
 
2.2 Chromatographic condition 
The analyses were performed on a reversed-phase Agilent Zorbax SB-C18 
(150 x 2.1 mm, i.d. 3.5µm, CPS analitica, Milan, Italy) protected by an Agilent 
Zorbax guard column, kept at 35°C, by a Surveyor system (ThermoFinnigan 
Italy, Milan, Italy) equipped with an autosampler kept at 4°C working at a 
constant flow rate (250 µL/min). 20 µL of sample were injected and the 
anthocyanins were eluted with a 38 min multistep gradient of phase A 
H2O/HCOOH (100/1 % v/v) and phase B CH3CN/CH3OH/HCOOH (50/50/1 % 
v/v): 0-3 minutes, isocratic of 5% B; 3-8 minutes, from 5% B to 15 % B; 8-13 
minutes, from 15% B to 28% B; 13-25.5 minutes, from 28% B to 32% B; 25.5-
28 minutes, from 32% B to 50% B; 28-33 minutes, isocratic of 50% B; 33-34 
minutes from 50% B to 5% B and then 34-38 minutes of isocratic 5% B. 
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2.3 Qualitative profile of Mirtoselect® anthocyanins 
The qualitative analysis of the fifteen anthocyanins was performed on a LTQ-
Orbitrap XL mass spectrometer using an ESI source (Thermo Scientific, Milan, 
Italy). Mirtoselect® 50 µg/mL, corresponding to 18 µg/mL of total 
anthocyanins, was analyzed working in full scan mode. Source parameters: 
spray voltage 4.5 kV, capillary temperature 270°C, capillary voltage 38 V, tube 
lens offset 110 V. A list of 20 background ions was adopted as lock mass 
values for real time mass calibration [24]. Mass spectra were acquired by the 
Orbitrap analyzer in positive ion mode using: profile mode, scan range m/z 
100-700, AGC target 5 × 105, maximum inject time 1000 ms, resolving power 
100000 (FWHM at m/z 400). The identification was obtained by using the 
exact mass. 
2.4 Characterization of MS/MS product ions for Multiple Reaction Monitoring 
analyses 
A multiple reaction monitoring (MRM) method was set up for the quantitative 
analyses. Mirtoselect® (50 µg/mL corresponding to 18 µg/mL of total 
anthocyanins) and the internal standard (1 µg/mL) dissolved in phase A were 
infused into the mass spectrometer at a flow rate of 10 µL/min to characterize 
the product ions of each compound. The fragmentation was performed in CID 
mode. The MS/MS analyses were performed with a TSQ Quantum Triple 
Quadrupole (Thermo Finnigan Italy, Milan, Italy) mass spectrometer fitted with 
an electrospray (ESI) interface operating in positive ion mode and with the 
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following source parameters: capillary temperature, 270°C; spray voltage 4.5 
kV; capillary voltage, 35 V; and tube lens voltage 106 V. The parameters 
influencing the transitions were optimized as follows: argon gas pressure in 
the collision Q2, 1.0 mtorr; peak full width at half-maximum (fwhm), 0.50 m/z 
at Q1 and Q3; scan width for all MRM channels, 0.5 m/z; and scan rate (dwell 
time), 0.05 s/scan. 
 
2.5 Preparation of calibration curve and QC samples 
Sample preparation was optimized starting from that reported by Morazzoni 
et al. [25]. Samples for calibration curves were obtained by spiking a water 
solution of Mirtoselect® in blank plasma in order to reach the following final 
concentrations of anthocyanins: 3.6, 9.0, 18.0, 36.0, 90.0, 180.0, 360.0, 720.0 
ng/mL. Samples were then spiked with the internal standard to reach a final 
concentration of 2.5 µM. After adding trichloroacetic acid (TCA, 5% as final 
concentration), samples were centrifuged at 8000 rpm for 10 minutes at 4°C 
and filtered on 0.45 µm Millex-LH filters (Millipore, Milan, Italy). The calibration 
curves (five replicates) were built by plotting the ratios (analyte/IS) between 
the sum of the areas under the peak of the fifteen anthocyanins and the the 
internal standard versus the nominal concentrations using a linearly weighted 
(1/x2) least squares regression. Data processing was performed by Xcalibur 
2.0 software. QC samples used in the validation were prepared as calibration 
samples at three different anthocyanin concentrations: 3.6, 36.0, and 720.0 
ng/mL. 
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2.6 Method validation 
Method validation was performed based on US FDA guidelines for 
bioanalytical method validation 
(http://www.fda.gov/downloads/Drugs/Guidance/ucm070107.pdf) . The 
parameters evaluated were: selectivity, linearity and LLOQ, precision, 
accuracy, stability and carry-over effect. 
 
2.7 Pharmacokinetic study 
28 male Sprague Dawley rats (6 weeks old, 220 g of average body weight) 
were housed in cages (two animals/cage) at 21.5 ± 1.5° C under a 12 h 
light/dark cycle. All the animal procedures (including housing, health 
monitoring, restraint, dosing, etc) and ethical revision were performed 
according to the current Italian legislation (Legislative Decree March 4th, 2014 
n. 26) enforcing the 2010/63/UE Directive on the protection of animals used 
for biomedical research. The rats were divided into four groups: the first group 
was not subject to a particular diet or starvation (they were allowed to eat 
4RF21 GLP pellets ad libitum, supplied by Mucedola), the other groups were 
allowed only to drink water ad libitum for 18 hours before the treatment. All the 
groups were orally treated by gavage with the relative formulation  
(Mirtoselect® dry extract dissolved in water or in water plus glucose or only 
water plus glucose) prepared extemporaneously on the basis of the rat’s 
weight. The fed rats were treated with 100 mg/kg Mirtoselect® (Group 1). The 
three groups of fasted rats underwent the following treatments: one group was 
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treated with 100 mg/kg Mirtoselect® (Group 2), one group was treated with 
100 mg/kg Mirtoselect® and 1 g/kg glucose (Group 3) and the last group was 
treated only with 1 g/kg glucose (Group 4) as a control group of Group 3. Blood 
sample aliquots were withdrawn from the retro orbital sinus under anesthesia 
(isoflurane) before administration and after 5 min and 0.25, 0.5, 1, 2, 3, 6, 24 
hours of the single oral dose. 
Blood was put in heparinized tubes and within 30 minutes centrifuged at 
10000g for 3 minutes at 4°C and plasma samples stored at -80°C until 
analysis. Plasma samples were prepared by adding 50 µL of 10% TCA and 
the internal standard to 50 µL of plasma samples, then centrifuged at 8000 
rpm for 10 minutes at 4°C and filtered on 0.45 µm Millex-LH filters (Millipore, 
Milan, Italy). The pharmacokinetic parameters were calculated with PK solver 
add-in program for Microsoft Excel. Animal studies were conducted by 
Accelera Srl (Nerviano, Italy) (study numbers: 2016-0087, 2016-0169, 2016-
0329). 
 
 
2.8 Modelling studies 
By considering the known transporters responsible for the glucose absorption 
at the gastro-intestinal level, computational studies involved homology 
modelling and docking simulations on the human glucose transporters sGLT1 
and GLUT2 [26]. Thus, the primary sequence of sGLT1 (P13866 
SC5A1_HUMAN) and GLUT2 (P11168 GTR2_HUMAN) was retrieved from 
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Uniprot and submitted to SwissModel server to search reliable templates and 
to build the corresponding homology models. With regard to sGLT1, 
SwissModel proposed 11 possible templates among which the mutated form 
of the Na+/glucose cotransporter from Vibrio parahaemolyticus was selected 
since it covers 75% of the sequence with an identity of 30%. Again, 50 
templates were proposed to model GLUT2 and the resolved structure of 
human GLUT1 was selected given its high coverage (90%) and identity 
(57.2%). The corresponding models were generated, refined and checked as 
described elsewhere.  
Given their acid-base equilibria, anthocyanins were simulated in their neutral 
state (quinoidal base) considering the three well-known tautomeric forms (A1, 
2-phenyl-5H-chromen-5-one; A2, 2-phenyl-7H-chromen-7-one; A3, 4-(2H-
chromen-2-ylidene)cyclohexa-2,5-dien-1-one) plus the corresponding 
hemiketal form in both resulting enantiomers. For simplicity’s sake, only the 
anionic form corresponding to A1 base was simulated, while the 
corresponding flavylium species were not investigated since they are stable 
only at very acidic pH ranges. Their conformational profile was investigated 
through MonteCarlo simulations and the so generated lowest energy 
structures were finally optimized by semi-empirical PM7 calculations using 
MOPAC2012. Docking simulations were performed by using PLANTS 
focusing the search within a 10 Å radius sphere around Gln314 for GLUT2 
and Asp161 for sGLT1. The poses were ranked by using the ChemPLP 
function with a speed equal to 1. The generated best complexes were then 
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minimized and rescored by using ReScore+ [27]. The computed scores were 
finally utilized in correlative studies as performed by the Vega suite of 
programs [28]. The reported equations were generated by including at most 
two independent and non collinear (i.e. VIF < 5) variables which were selected 
by exhaustively combining all computed scores.    
 
3. Results 
3.1 Optimization of HPLC–MS/MS and HPLC-orbitrap method 
MS detection was performed in positive ion mode in both an orbitrap and triple 
quadrupole MS analyzers. MS parameters of collision energy (CE), spray 
voltage, capillary voltage and tube lens voltage were optimized in both the 
instruments by infusing a standard solution of Mirtoselect to achieve 
maximum responses of precursor and product ions. To achieve good 
chromatographic behaviours and high responses of analytes, methanol and 
acetonitrile were tested as organic phase, and a higher chromatographic peak 
response was obtained when choosing a mixture of methanol and acetonitrile. 
We also investigated one additive, formic acid for the enhancement of 
ionization at two different percentages: 0.1% and 1% and the latter was found 
to be the suitable percentage.  
3.2 Development of sample preparation procedure 
Two different protein precipitation methods were investigated: precipitation 
with solvent and with acid. When samples were pre-treated with acetonitrile, 
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recovery was low and a strong matrix interference was observed. The solvent 
precipitation was performed according to Morazzoni P et al. [25]  which 
consisted of treating 0.5 mL of plasma with 0.5 mL 10% TCA  and, after 
centrifugation, the precipitates were washed with 1 mL 5% TCA. We found 
that by eliminating the last step (washing procedure) the recovery was 
improved without impacting selectivity and matrix effects. Moreover the acid 
conditions permitted the maintenance of anthocyanins in the stable flavylium 
cation form. 
3.3 Profiling plasma anthocyanins and metabolites by LC-ESI-orbitrap 
Identification of anthocyanins in rats treated with Mirtoselect® was firstly 
carried out by using an orbitrap as mass analyzer. Identification of the analytes 
was obtained by accurate mass and on the basis of the isotopic and 
fragmentation pattern, analyzing 0.25 and 0.5 h time point samples. As an 
example, in Figure 1 is reported the identification of Cya-3-O-ara in a plasma 
sample withdrawn after 0.25 h Mirtoselect® ingestion. Anthocyanins were 
finally identified by comparing the relative retention time with that of the 
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standard components contained in Mirtoselect®. Table 2 summarizes the 
analytes identified with the relative retention times.  
 
Figure 1 – Identification of Cya-3-O-ara in a plasma sample withdrawn after 0.25 h Mirtoselect® 
ingestion. LC-ESI-MS analysis by using an orbitrap as MS analyzer: (A) Single ion 
chromatogram at m/z 419.09782; panel (B) shows the full MS spectrum reporting the 
experimental m/z value at 419.09726 (Δ ppm= -0.033) and the relative isotopic pattern; LC-
ESI-MS analysis by using a triple quadrupole as MS analyzer: (C) MRM ion chromatogram 
using the transition m/z 419 → 287; (D) product ion MS spectrum setting the ion at m/z 419 as 
parent ion. 
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Anthocyanin 
Calculated 
[M]+ 
Experimental 
[M]+ 
Δ ppm Formula 
RT min 
(RSD%) 
Cya-3-O-ara 419.09782 419.09726 -0.033 C20H19O10+ 13.72 (0.94) 
Peo-3-O-ara 433.11347 433.11322 0.684 C21H21O10+ 16.53 (1.34) 
Del-3-O-ara 435.09273 435.09219 0.004 C20H19O11+ 12.27 (1.11) 
Cya-3-O-gal 449.10838 449.10788 -0.041 C21H21O11+ 12.17 (1.00) 
Cya-3-O-glu 449.10838 449.10788 -0.041 C21H21O11+ 12.88 (1.02) 
Pet-3-O-ara 449.10838 449.10788 -0.041 C21H21O11+ 14.81 (1.47) 
Peo-3-O-gal 463.12403 463.12335 -0.299 C22H23O11+ 14.62 (1.24) 
Peo-3-O-glu 463.12403 463.12335 -0.299 C22H23O11+ 15.48 (1.03) 
Mal-3-O-ara 463.12403 463.12335 -0.299 C22H23O11+ 17.30 (1.62) 
Del-3-O-gal 465.10330 465.10266 -0.200 C21H21O12+ 10.96 (0.84) 
Del-3-O-glu 465.10330 465.10266 -0.200 C21H21O12+ 11.46 (0.89) 
Pet-3-O-gal 479.11895 479.11838 -0.048 C22H23O12+ 13.15 (1.36) 
Pet-3-O-glu 479.11895 479.11838 -0.048 C22H23O12+ 13.77 (0.95) 
Mal-3-O-gal 493.13460 493.13388 -0.351 C23H25O12+ 15.41 (0.76) 
Mal-3-O-glu 493.13460 493.13388 -0.351 C23H25O12+ 16.16 (0.85) 
Table 2 – Anthocyanins identified in plasma samples of rats after 0.25 h the oral administration 
of 100 mg/Kg of Mirtoselect®. Identification was achieved by LC-ESI-MS and using an orbitrap 
as mass analyzer. 
 
3.4 Quantitative analysis of anthocyanins in plasma 
Quantitative analysis of anthocyanins was then carried out by using an HPLC 
connected with a triple quadrupole set in MRM mode. The retention time of 
each anthocyanin as determined by HPLC-ESI orbitrap and HPLC-ESI-TSQ 
showed a minimum shift because of the different HPLC void volumes. Table 
3 summarizes the transitions used.  Calibration curves were built by spiking 
Mirtoselect® to plasma samples and plotting the concentration versus the ratio 
between the sum of the area of each anthocyanin and the IS.  
IV – Study 2 
 
126 
 
This method permits the determination of the overall plasma concentration of 
anthocyanins but not their individual absolute content. The amount of each 
anthocyanin was determined as a relative percentage in respect to the overall 
content of anthocyanins. 
 
 
 
 
 
 
 
 
Table 3 – Precursor and product ion pairs for MRM analysis of anthocyanins and Naringenin-
7-O-glucoside chosen as internal standard. 
 
Anthocyanins, as well as the internal standard, are characterized by the loss 
of the sugar moiety as a neutral loss. The major product ion is the aglycone, 
Name 
Parent ion  
(m/z) 
Product ion 
 (m/z) 
Collision  
energy (V) 
Cya-3-O-ara 419 287 20 
Peo-3-O-ara 433 301 20 
Del-3-O-ara 435 303 20 
Cya-3-O-gal 449 287 20 
Cya-3-O-glu 449 287 20 
Pet-3-O-ara 449 317 20 
Peo-3-O-gal 463 301 20 
Peo-3-O-glu 463 301 20 
Mal-3-O-ara 463 331 20 
Del-3-O-gal 465 303 20 
Del-3-O-glu 465 303 20 
Pet-3-O-gal 479 317 20 
Pet-3-O-glu 479 317 20 
Mal-3-O-gal 493 331 20 
Mal-3-O-glu 493 331 20 
Naringenin-7-O-glucoside 435 273 15 
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detected as [M]+ ions for anthocyanins (Figure 2) and as [M+H]+ for the internal 
standard.  
 
 
 
Figure 2 – Representative MRM chromatograms of anthocyanin arabinosides in blank plasma 
(left panel), blank plasma spiked with Mirtoselect® at LLOQ (middle panel) and plasma 
sample collected after 0.25 h of Mirtoselect® administration (right panel). (A) Cya-3-o-ara, (B) 
Peo-3-O-ara, (C) Del-3-O-ara, (E) Pet-3-O-ara. Please note that the RT of the analytes 
identified by the LC-ESI-triple quadrupole are slight different in respect to the values 
determined by LC-ESI-orbitrap due to different void volumes. 
IV – Study 2 
 
128 
 
 3.4.1. Selectivity 
Typical MRM chromatograms relative to the anthocyanin arabinosides and 
obtained from a blank sample, a spiked plasma sample with Mirtoselect® (at 
LLOQ) and IS, and a plasma sample after 0.25 h of the administration of 
Mirtoselect® 100 mg/kg are shown in Figure 2. No interference of endogenous 
peaks were exhibited in blank plasma samples collected from 7 different rats 
thus indicating the high selectivity of the method.  
 3.4.2. Linearity and LLOQ  
The method was validated over a range of 3.6-720.0 ng/mL of total 
anthocyanins. The r2 values of the five calibration curves were > 0.997. The 
R.S.D. values on the slope were below 15%. Mean regression parameters 
are: y = 4.419 (± 0.06234) x - 0.04810 (± 0.01726). The LLOQ was 3.6 ng/mL 
with a R.S.D. < 5% and a bias < 18%.  
          3.4.3. Precision and accuracy 
The intra- and inter-day precision and accuracy obtained by QC samples are 
listed in Table 4. The RSD values of all analytes were less than 15.67% and 
the accuracy ranged from -19.3% to 14.82% (bias%). The results indicated 
that this method is reliable and reproducible enough for further 
pharmacokinetic studies. 
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Anthocyanins 
concentration ng/mL 
Intra-day (n=5)   Inter-day (n=15) 
Precision 
(RSD, %) 
Accuracy 
(Bias %) 
  
Precision 
(RSD, %) 
Accuracy  
(Bias %) 
3.60 15.67 -19.30  4.94 14.82 
36.00 5.23 -4.86  9.42 8.29 
720.00 2.92 0.81   2.37 1.57 
Table 4 –Intra-day and inter-day precision and accuracy of the method. 
 
 3.4.4 Stability 
Samples were tested only for two cycles of freeze-thaw. After one cycle of 
freeze-thaw anthocyanins were stable (±13%) while after two cycles they were 
no longer stable (loss > 50%). Anthocyanin concentration after 18 hours at 
4°C fell within the ±15% range and so can be considered stable for the time 
analyses. 
          3.4.5 Carry-over effect 
Carry-over of all analytes in blank sample following the high concentration 
standard (ULOQ) was not greater than the 20% of the LLOQ and 5% for the 
IS. 
3.5 Pharmacokinetic study 
The quantitative method was then applied to measure the concentrations of 
total anthocyanins in plasma samples of Groups 1, 2 and 3 at different time 
points (Figure 3).  In Table 5 are reported the relative pharmacokinetic 
parameters AUC, TMAX and CMAX, calculated with PK solver add-in program for 
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Microsoft Excel. The plasma concentration peak was reached after 0.25 h for 
Group 2, while for the other two groups the peak was at 0.5 h. 
 
  AUC 0-t (ng/mL*h) Tmax (h) Cmax (ng/mL) 
Group 1 18.67 (0.90) 0.50 (0.00) 10.79 (1.02) 
Group 2 139.05 (33.75) 0.25 (0.00) 75.60 (23.14) 
Group 3 160.79 (21.26) 0.50 (0.00) 90.73 (32.92) 
Table 5 – Mean and SEM of pharmacokinetic parameters of anthocyainis following 100 mg/Kg 
dose of Mirtoselect® 
 
Figure 3 - Plasma profile of anthocyanins in Group 1 (Fed rats treated with 100 mg/kg Mirtoselect®), 
Group 2 (Fasted rats treated with 100 mg/kg Mirtoselect®) and Group 3 (Fasted rats treated with 100 
mg/kg Mirtoselect® and 1g/kg glucose). The lower graph is a blow-up of the 0-2 hours. 
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The data well indicate that the fasting condition significantly increases the 
bioavailability of anthocyanins by more than 7 fold in respect to fed rats. 
Several reasons could explain the effect of food intake in reducing 
anthocyanin availability, such as the matrix effect and the interaction of 
anthocyanins with food components (proteins and lipids) and the effect of 
fasting on GLUT expression. We then used fasting rats to understand the 
effect of glucose intake on anthocyanin PK. The AUCs of anthocyanins given 
as such or with glucose were found superimposable and not significantly 
different, thus suggesting that glucose does not interfere with the overall 
anthocyanin uptake. The difference between the two curves can be found in 
the TMAX which was shifted by 15 min when glucose was added to 
anthocyanins thus indicating that glucose co-administration affects the kinetic 
but not the overall amount of absorbed anthocyanins.  By contrast, it has been 
found by others in in vitro and ex vivo conditions [10, 22, 30] that anthocyanins 
inhibit glucose absorption thus indicating that the binding constant of 
anthocyanins and glucose towards GLUT transporters should be quite 
different.  
The plasma content of each anthocyanin was then determined as a relative 
percentage in respect to the total amount of anthocyanins. Then, to compare 
the different bioavailability of anthocyanins, the relative plasma content of 
each anthocyanin was compared to that determined in Mirtoselect®. Based 
on this comparison, an anthocyanin better absorbed in respect to the others 
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contained in the mixture would be characterized by a relative content in 
plasma higher in respect to its relative content in the mixture. Therefore, the 
fifteen constituents can be divided into three classes: A) anthocyanins 
showing a relative abundance in plasma higher in respect to extract (more 
absorbed, Figure 4A); B) anthocyanins with no significant difference of relative 
abundance between plasma and extract (Figure 4B); C) anthocyanins with a 
plasma relative abundance lower in respect to that determined in the extract 
(less absorbed, Figure 4C). By comparing the anthocyanins characterized by 
the same anthocyanidin moiety but with the variable sugar moiety, the 
following rank could be considered: Cya-3-O-gal > glu >> ara; Peo-3-O-gal > 
glu >> ara; Del-3-O-gal > glu > ara; Mal-3-O-gal ~ glu > ara; Pet-3-O-gal > glu 
> ara. 
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It is quite clear that the sugar moiety greatly affects absorption and that gal 
and glu, at least for Cya and Peo, significantly favour the absorption while ara, 
for all the anthocyanins, is detrimental. These results are in line with those 
reported by Ichiyanagi, T.  et al. [31] 
The aglycone moiety too was found to affect absorption. This is well evident 
for glucoside since of the four anthocyanins containing the glu moiety, 
Figure 4 – Relative abundance of Mirtoselect® anthocyanins in plasma in respect to the 
extract. Based on the difference in relative abundances, the 15 anthocyanins were divided 
into three groups: A) anthocyanins showing a relative abundance significantly higher in 
plasma in respect to extract and hence more absorbed; B) anthocyanins with no significant 
difference of relative abundance between plasma and extract; C) anthocyanins with a 
plasma relative abundance lower in respect to that determined in the extract and hence less 
absorbed. Empty bar: relative abundance in plasma; Filled bar: relative abundance in 
Mirtoselect®; * = p<0.05 
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Cyanidin-3-O-glucoside was significantly more absorbed in respect to the 
other glucosides, suggesting that Cyanidin moiety enhances bioavailability 
(Table 6). 
Anthocyanins Variation (%) 
Cya-3-O-gal 70.16 
Cya-3-O-glu 14.68 
Peo-3-O-gal 88.46 
Peo-3-O-glu 42.27 
Del-3-O-gal 11.96 
Mal-3-O-glu 2.04 
Mal-3-O-gal 0.37 
Pet-3-O-gal -11.26 
Del-3-O-glu -18.06 
Mal-3-O-ara -44.65 
Pet-3-O-glu -21.03 
Cya-3-O-ara -41.52 
Del-3-O-ara -60.54 
Pet-3-O-ara -77.70 
Peo-3-O-ara -63.14 
Table 6 – Relative absorption of anthocyanins deteremined as follows: (%plasma-
%Mirtoselect®)/%Mirtoselect®)x100 where %plasma is the relative content of anthocyanin in 
plasma determined at the Tmax and %Mirtoselect® is the relative content in the standardized 
extract given to rats by gavage. Relative absorption was used as dependent variable in 
correlative analyses. 
 
3.6 Computational analyses 
As mentioned in the Introduction, computational studies were performed i) to 
better elucidate the molecular recognition between anthocyanins and GLUT2 
and sGLT1; ii) to understand their role on anthocyanin absorption and in 
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particular to understand which transporter better explains the different 
absorption found among the 15 anthocyanins as determined in the PK studies, 
iii) to investigate which electrical form is involved in the transport process. 
Moreover, the simulations were focused on the GLUT2 isoform which is 
principally expressed at the intestinal level even though the obtained results 
might be extended to the other GLUT isoforms due to the high homology 
degree between them.  
With regard to GLUT2, Figure 5 compares the putative complexes computed 
for highly transported (i.e. cyanidin-3-O-galactoside, 5A) and poorly 
transported (i.e. petunidin-3-O-arabinoside, 5B) ligands as simulated in their 
most effective quinodal base (A1, see statistics in Table 7). In detail, Figure 
5A reveals a very rich interaction pattern which can be roughly subdivided into 
three parts: (a) almost all sugar hydroxyl functions are engaged in a network 
of H-bonds involving Gln314, Gln315, Asn320 and Asn443; (b) the 5H-
chromen-5-one ring is involved in an extended π-π stacking with Trp420 plus 
H-bonds with Ser169 and Gln193; (c) the 3,4-dihydroxyphenyl moiety elicits 
H-bonds with Glu412. As evidenced in Figure 5B, such an interaction network 
can clearly explain the poor recognition of peonidin-3-O-arabinoside which 
loses an H-bond involving the sugar moiety, while the 3 methoxyl group 
bumps against Gln193 and Pro417 weakening the interactions stabilized by 
the aglycone moiety. Nevertheless it should be noted that the replacement of 
a hydroxyl function by a methoxy group is not necessarily detrimental to the 
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overall transport as evidenced by peonidin-3-O-galactoside which shows a 
relative absorption even better than cyanidin-3-O-galactoside. As detailed 
below, a fine balance between polar and apolar contacts has a clearly 
beneficial role on the transport by both proteins. The other two neutral 
tautomers show similar interaction patterns apart from the A1 base which 
shows a slightly translated pose of the quinone ring to minimize the possible 
repulsion between carbonyl oxygen atom and Glu412. Such a shift induces a 
slight worsening of all monitored interactions.  
Figure 5 - Major interactions stabilizing the putative of Cyanidin-3-O-galactoside (5A) and 
Petunidin-3-O-arabinoside (5B) with GLUT2. Residues interacting with sugar moiety are 
labeled in blue, residues interacting with the aglycone in red. 
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Transporter N Form R2 Q2 Equation 
GLUT2 
1 Base_A1 0.71 0.55 −0.72 − 1.47 MLPInS_2 − 0.011 Elect 
2 Base_A2 0.47 0.24 
−16.51 + 4.16 XScore + 21.42 
ContactsH 
3 Base_A3 0.58 0.34 −0.13 − 9.02 MLPInS + 0.027 Elect 
4 Anion_A- 0.62 0.42 −25.35 + 0.19 Elect + 3.93 XScoreHM 
5 Hemiketal 0.44 0.24 7.46 − 0.11 MLPInS + 2.07 PLP95H 
6 Base_Mean 0.77 0.61 
11.57 − 31.17 MLPInS + 0.18 
CHEMPLP 
sGLT1 
7 Base_A1 0.67 0.51 −15.09 + 2.44 XScoreHP − 2.16 MLPInS 
8 Base_A2 0.66 0.49 0.69 − 0.099 MLPInS + 0.047 Elect 
9 Base_A3 0.58 0.39 9.24 − 0.15 MLPInS − 0.08 PLP95 
10 Anion_A- 0.7 0.5 −0.82 − 0.10 MLPInS + 0.032 Elect 
11 Hemiketal 0.57 0.45 −6.71 + 3.71 PLP95H + 3.25 XScoreHS 
12 Base_all 0.76 0.62 
−1.89 + 247.52 ContactsWA1 − 0.17 
PLPA2 
13 Base_mean 0.78 0.65 −0.52 − 0.17 MLPInS + 0.032 Elect 
14 Base_mean + Anion 0.82 0.7 
−2.49 − 0.19 MLPInS_A- + 0.042 
Elect_mean 
Table 7. Predictive equations as generated for GLUT2 and sGLT1 transporters by considering 
separately each simulated form (Eqs 1–5 and 7–11), by including the score averages for the 
three neutral tautomers (Eqs. 6 and 13) by considering simultaneously the scores of the neutral 
species (Eq. 12) or combining he score averages for the three neutral tautomers with the scores 
of the anionic form (Eq. 14). Notice that the corresponding Eqs 12 and 14 for GLUT2 are not 
reported since they did not give satisfactory results. The models for hemiketals (Eqs. 5 and 11) 
were generated by averaging the scores for the two resulting enantiomers. 
 
Again, the hemiketal forms yield complexes similar to those shown in Figure 
5A with the added hydroxyl group which contacts Gln193 and Gln314 in the 
(R) and (S) isomers, respectively. Due to the above mentioned electrostatic 
repulsion with Glu412, the simulated anionic form assumes a substantially 
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different pose in which the sugar ring approaches Ser169 and Ser112 and the 
aromatic system loses several key contacts.     
Similarly to Figure 5 and with regard to sGLT1, Figure 6 compares the 
complexes computed for highly (i.e. cyanidin-3-O-galactoside, 6A) and poorly 
transported (i.e. petunidin-3-O-arabinoside, 6B) ligands as simulated in their 
most effective neutral tautomer (A1, see below). Also here, the numerous 
interactions stabilized by cyanidin-3-O-galactoside can be subdivided in three 
groups: (a) the sugar hydroxyl functions elicit H-bonds with His83, Asp161, 
Tyr290, Ser393; (b) the 5H-chromen-5-one ring elicits a π-π stacking 
interaction with Tyr290 plus H-bonds with Thr460 and to a minor extent with 
Lys157; (c) the 3,4-dihydroxyphenyl moiety is engaged in π-π stacking 
interactions with Phe101 and Trp291 while the hydroxyl functions are involved 
in a rich network of H-bonds with Asn78, Glu102 and Lys321. Similarly to what 
was observed for GLUT2, Figure 6B shows that the sugar moiety of petunidin-
3-O-arabinoside loses the H-bond with Tyr290, while the phenyl moiety is 
constrained to assume a slightly different arrangement where the 4-hydroxy 
functions interact with the above mentioned polar residues, while the methoxyl 
group approaches Leu87. The A2 neutral tautomers provide interaction 
patterns almost superimposable on A1 bases, while the A1 forms reveal 
overturned poses in which the 5H-chromen-5-one ring stabilizes H-bonds with 
Asp161 and the quinone ring contacts Thr460 and Gln457 (complexes not 
shown). Finally, the putative complex between sGLT1 and cyanidin-3-O-
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galactoside in the simulated anionic form reveals a slightly different pose 
which appears to be vastly stabilized by the ion-pair between the negatively 
charged chromene ring and Lys157. When comparing the poses assumed in 
the two transporters by the simulated forms, one may notice a greater 
versatility of sGLT1 compared to GLUT2. Indeed, while GLUT2 conveniently 
accommodates the neutral A1 tautomer, sGLT1 appears to be able to 
accommodate almost all simulated species which assume slightly different 
poses which mostly differ in the arrangement of the aglycone while the sugar 
moiety acts as a pivot by stabilizing roughly constant interactions. Such a key 
difference in the interaction pattern between the two simulated transporters is 
ascribable to the different role of the ionized residues. The molecular 
recognition by GLUT2 is indeed heavily influenced by the only charged 
residue lining the GLUT2 binding cavity, namely Glu412, the negative charge 
of which renders the pocket highly selective and prevents a proper 
accommodation of both some neutral tautomers (i.e., A3) and the anionic 
species. In contrast, the binding cavity of sGLT1 is flanked by more positively 
and negatively charged residues (i.e. Glu102 and Lys321) which variously 
participate in the substrate recognition and increase the versatility of the cavity 
which is thus able to conveniently harbour almost all simulated ligand forms. 
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Figure 6 – Major interactions stabilizing the putative of Cyanidin-3-O-galactoside (5A) and 
Petunidin-3-O-arabinoside (5B) with sGLT1. Residues interacting with sugar moiety are labeled 
in blue, residues interacting with the aglycone in red. 
 
The different versatility of the two transporters is reflected in the correlative 
models reported in Table 7 2GV1. Indeed, the correlative equations developed 
for the three neutral tautomers in GLUT2 (Eqs. 1-3) clearly differ in their 
statistical reliability with only the A1 forms yielding a satisfactory model (see 
Eq. 3). Again hemiketal and anionic species do not offer relevant equations 
(Eqs 4-5), while equations obtained combining or averaging the docking 
scores of more simulated species reveal limited synergistic effects and only 
the model including the score averages of the three quinodal bases (Eq. 6) 
evidences a modest improvement compared to the Eq. 3.  
In contrast, the equations developed for sGLT1 show limited differences with 
both A1 and A2 tautomers yielding similarly satisfactory models (Eq. 8-9) as 
well as the anionic species (Eq. 10). Again, combinations and averaging of 
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more docking scores provides here more interesting results and the best 
model (Eq. 14) is developed by combining the average scores for the three 
neutral forms with the score for anionic ligands. 
Collectively, the reported models allow for some key considerations. First, the 
two simulated transporters yield roughly comparable models which suggest 
that both proteins might be similarly involved in the transport of anthocyanins 
and thus responsible for the observed differences in their absorption. Second 
and as detailed above, the key difference between GLUT2 and sGLT1 
involves the greater flexibility of the latter which seems to be able to recognize 
almost all simulated forms while the former shows a clear preference for a 
specific neutral tautomer (A1). Third and while avoiding a systematic 
description of all included docking scores, the generated equations emphasize 
that a good substrate has to stabilize a balanced set of polar and hydrophobic 
interactions. Surprisingly, the score encoding for ionic contacts is often 
included with a positive sign (see the best Eq. 14) thus suggesting that ligands 
stabilizing too strong polar contacts can remain trapped within the binding 
pocket thus acting as transport blockers. In contrast, ligands stabilizing a 
proper set of polar and apolar contacts are suitably recognized without 
hampering the transport turn-over. 
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4. Conclusions 
By using a validated LC-ESI-MS method we found that 15 bilberry 
anthocyanins behave differently in term of bioavailability and that both the 
aglycone and the sugar moiety significantly affect the PK profile. Such 
different behaviour can be well explained by considering the involvement of 
glucose transporters as supported by computational studies which have found 
a significant correlation between the relative absorption of each anthocyanin 
and their GLUT2 and sGLT1 molecular recognition.  
Finally, although modelling and docking simulations were performed on 
human glucose transporters sGLT1 and GLUT2, the results of this study 
cannot be easily transposed to humans, due to the fact that bioavailability and 
metabolism of flavonoids is species specific. Hence an intervention study in 
humans should be performed in order to confirm the involvement of glucose 
transporters in anthocyanin absorption. We believe that the study here 
reported can help the realization of this future study, having defined the 
analytical and computational approaches which can be easily transferred to 
the human study.   
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Abbreviations: Cya, Cyanidin; Peo, Peonidin; Pet, Petunidin; Del, 
Delphinidin; Mal, Malvidin; Ara, arabinoside; Gal, Galactoside; Glu, Glucoside. 
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Plants are a rich source of bioactive compounds and their use as therapeutic 
agents dates back since ancient times. However, the complexity of their 
composition still limits the complete characterization of the bioactive 
compounds, their mechanisms of action and ADME profiles. These limitations 
are due to the lack of suitable analytical methods and leading to a reduced 
application of plant based products, which have a great potential in the 
treatment of several pathologies. In light of all these considerations, the aim 
of this Ph.D thesis was to set up high resolution mass spectrometric and 
selective MS/MS methods to characterize and identify bioactive molecules 
present in plant extracts and to understand their mechanisms of action and 
their bioavailability in human and in rodents. The results reported in the 
present Ph.D thesis demonstrate how novel mass spectrometric strategies 
can be applied to obtain the same information as that obtained for pure 
compounds in the discovery stage. 
In particular, MS strategies were applied to investigate the ability of plant 
extracts  to act as a) sequestering agents of reactive carbonyl species, toxic 
lipid peroxidation products involved in the pathogenetic mechanisms of 
several inflammatory based disorders and b) as protein precipitation agents 
(tannin effect) using bradykinin, a pro-inflammatory mediator, as protein 
target; and to study the ADME profiles of a) a standardized cranberry extract 
in humans and b) a standardized bilberry extract in rodents. 
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The activity of different rice extracts to inhibit protein carbonylation was tested 
by using a HRMS method. The screening analysis showed that black rice with 
giant germ extract was the most active. A novel MS strategy based on a 
specific isotopic labelling was then applied to identify the active compounds, 
which are represented by some anthocyanidins and aminoacids. 
Tannin protein precipitation extent was quantified by a fast and reliable LC-
MS method, which was developed by using tannic acid and penta-O-galloyl-
β-D-glucose as tannin agents and bradykinin as a peptide model. The method 
allowed us to get easily quantitative data, so it can be used as an in vitro 
screening of several plant extracts and compounds able to complex and 
precipitate damaging target peptides. 
The controversial results present in the literature on the bioactive compounds 
of cranberry, used in the prevention of urinary tract infections, are mainly due 
to different dosages and non-standardized treatments. The activity was 
associated with PACs by several in vitro studies, but in vivo they seemed to 
be absent in urine. Moreover some in vivo studies are limited to the research 
in human urine of known compounds and metabolites. The use of a 
standardized extract and a dosage found effective in human studies 
associated with a HRMS method and the on target and off target data 
analyses adopted in the present Ph.D thesis, aimed to overcome these limits. 
35 metabolites were identified and some of them are PACs metabolites. The 
ex-vivo study performed on the inhibition of C. albicans adhesion by urine 
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fractions allowed attention to be focused on the major compounds present in 
the active fractions. 
Anthocyanins health benefits, related to their antioxidant, anti-inflammatory 
and anticarcinogenic properties, have long been reported but less is known 
about their mechanism of absorption. Among the mechanisms proposed there 
is the GLUT transporters. The aim of this work was to better understand the 
role of GLUT transporters (GLUT2 and sGLT1) in anthocyanin absorption by 
applying a selective and sensitive HPLC-MS/MS method to a pharmacokinetic 
study in rats. Three different conditions were investigated: fed, fasting 
conditions and fasting conditions with glucose co-somministration. The results 
obtained in conjunction with those achieved by docking studies confirm the 
GLUT2 and sGLT1 involvement in anthocyanin absorption. 
In conclusion, the development of different MS strategies has improved the 
knowledge of the mechanisms of action, bioactivity and bioavailability of the 
plant extracts investigated. The examples reported in the present thesis 
confirm that information usually obtained for pure compounds in the discovery 
stage can also be retrieved for more complex bioactive products such as plant 
extracts. Plant extracts which nowadays find a wide use as health products 
should be better characterized in terms of biological activity and 
pharmacokinetic, thus assuring greater efficacy and safety and the fact they 
are a complex matrix should not limit this information. 
  
 
 
 
 
 
 
 
 
Appendix 
 
Appendix 
 
152 
 
1. Bioactive components of plants 
The molecules with a potential pharmacological interest present in plants are 
the secondary metabolites, which are synthesized by plants as mechanism of 
defence. These compounds are represented by polyphenols, terpenoids and 
alkaloids. In particular, a great interest was shown in polyphenols, that are the 
most abundant and heterogeneous class. They are reported to have several 
health benefits [1]: their main ability is to act as antioxidant [2-4], but they were 
also found to be able to interact and modulate the activity of enzymes and 
receptors leading to several potential applications [5]. Polyphenols are 
classified in different classes on the basis of the number of phenol rings and 
the way in which they are linked together. We can distinguish : flavonoids, 
phenolic acids, stilbens and lignans [6]. Among these compounds several 
health benefits have been related to flavonoids [7-9], which are composed by 
a fifteen-carbon skeleton consisting of two benzene rings (A and B) linked via 
a heterocyclic pyrane ring (C) (Figure 1) [9]. 
 
Figure 1 – Basic flavonoid structure 
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Depending on the level of oxidation and on the substituents on the C ring, 
flavonoids can be subdivided in several classes : anthocyanins, flavonols, 
flavanones, flavones, iso-flavones, flavan-3-ols and other minor classes. 
Single compounds of each class differ in the pattern of substitution of the A 
and B rings [10] and they can exist as aglycone, glicoside and methylated 
derivatives. Flavonoids activity is related to their structure. 
Anthocyanins are natural pigments which give the blue, purple, red and 
orange colour of many fruits and vegetables [11]. The aglycone, named 
anthocyanidin, is characterized by several hydroxyl groups to which are bound 
one or more sugar moieties. The main sources of anthocyanin are red fruits, 
cereals, vegetables and red wine among drinks [12, 13]. Their potential 
applications towards oxidative-based diseases are supported by several 
studies reporting their antioxidant [14], anti-inflammatory [15] and 
anticarcenogenic properties [16]. 
Flavonols are the most ubiquitous flavonoid class present in foods, the main 
representatives are quercetin and kaempferol, and they are mainly present in 
glycosylated forms [6]. Some examples of foods rich in flavonols are onions, 
cherries, apples and broccoli [17]. In vitro and in vivo studies performed on 
quercetin aglycone and phase II metabolites have shown vasorelaxant and 
hypotensive effects [18, 19], but also anti-inflammatory properties [20]. It is 
also reported in an in vitro study that quercetin-3-O-glucuronide significantly 
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reduced the generation of β-amyloid peptides, but the activity can be limited 
by the permeability of the BEE [21]. 
Flavanones, such as hesperidin, naringenin and eriodictyol, are mostly found 
in citrus fruits [17]. They are associated to vascular benefits [22].  
Apigenin and luteolin, and their glycosilated forms, are the main 
representative of flavone class, which are known to have neuroprotective 
actions [23]. 
Isoflavones are flavonoids having a structure similar to estrogens. This 
similarity conferes them the ability to bind to estrogen receptors, so they are 
classified as phytoestrogens. Isoflavones are found almost exclusively in 
leguminous plants (e.g. soya) and their assumption was related to bone 
beneficial effects [24]. 
Flavanols or flavan-3-ols, also called catechins, can exist as monomeric or 
oligomeric and polymeric forms having different types of linkages. The 
oligo/polymers are named proanthocyanidins but they are also known as 
condensed tannins [25]. Monomeric flavanols (catechin and epicatechin) and 
their derivatives are the major polyphenols present in tea leaves [26], while 
proanthocyanidins are present in great amount into fruits, in particular in 
berries such as cranberries (Vaccinium macrocarpum), cereals and nuts and 
chocolate [27]. Several studies decribed their anti-oxidant, anti-inflammatory 
and anticarcenogenic properties, benefits on cardiovascular and diabetic 
complication, and antibacterial effects [28].  
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2. Bioavailability of flavonoids 
The biological fate of the dietary flavonoid glycosides has been a controversial 
issue over the years. Although many answers have now been provided, this 
issue is still far from established. Due to their chemical features, such as highly 
polarity, it was long believed that they could not be absorbed intact after oral 
ingestion, but they were hydrolyzed to their aglycones by bacterial enzymes 
in the lower part of the intestine [29, 30]. Further, aglycones might then be 
partially absorbed or may undergo a further biotransformation by bacteria. 
However, some scientific evidence have demonstrated that some flavonoid 
glycosides could be absorbed intact in the small intestine, using the sodium 
dependent glucose transporter 1 (SGLT1) as reported by  Hollman 1995;  it 
was verified that the efficiency of such absorption was dramatically 
suppressed by efflux of at least some flavonoid glycosides by the apical 
transporter multidrug resistance-associated protein 2 (MRP2). At the same 
time, a number of studies support the view that quercetin glycosides are not 
absorbed intact in humans or, rather, are not able to reach the systemic 
circulation [31, 32]. Similar findings have been observed for the intact 
glycosides of diosmetin [33] and luteolin [34], thus confirming the tendency of 
flavonoid glycosides to be hydrolyzed.  
A huge scenario of bioabsorption seems to be attributed to the different 
classes of flavonoid glycosides. Because absorption occurs less readily in the 
colon than in the small intestine because of a smaller exchange area and a 
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lower density of transport systems, as a general rule, glycosides with 
rhamnose are absorbed less rapidly and less efficiently than aglycones and 
glucosides. This has been clearly shown in humans for quercetin glycosides: 
maximum absorption occurs 0.5–0.7 h after ingestion of quercetin 4'-glucoside 
and 6–9 h after ingestion of the same quantity of rutin (quercetin-3-rutinoside). 
The bioavailability of rutin is only 15–20% of that of quercetin 4'-glucoside [32, 
35]. Similarly, absorption of quercetin is more rapid and efficient after ingestion 
of onions, which are rich in glucosides, than after ingestion of apples 
containing both glucosides and various other glycosides [36]. In the case of 
quercetin glucosides, absorption occurs in the small intestine, and the 
efficiency of absorption is higher than that for the aglycone itself [37, 38].  
 
In the small intestine, cleavage of the sugar unit is mediated through the action 
of cytosolic β-glucosidase [39] and lactase phloridzin hydrolase (LPH), located 
in the brush border of epithelial cells. LPH exhibits broad specificity for 
flavonoid-O-β-D-glucosides, and the released aglycones can enter the 
epithelial cells by passive diffusion due to their increased lipophilicity [40]. 
Both enzymes are probably involved, but their relative contribution for the 
various glucosides remains to be clarified. Quercetin 3-glucoside, which is not 
a substrate for cytosolic-glucosidase, is certainly absorbed after hydrolysis by 
lactase phloridzine hydrolase, at least in rats, whereas hydrolysis of quercetin 
4'-glucoside seems to involve both pathways.  
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The extent of absorption and bioavailability of drugs has long been known to 
be affected by membrane transporters, mainly efflux transporters, in addition 
to metabolism. The traditional efflux transporter for drugs i.e., P-glycoprotein, 
does not seem to be involved in the transport of flavonoids, mainly dependent 
on differences in chemical structures. However, other transporters have been 
found that may be important. This has been recognized mainly through the 
use of monolayers of the human intestinal Caco-2 cells or intestinal rat 
preparations. These transporters include the absorptive transporter SGLT1, 
identified in both Caco-2 cells [41] and the rat small intestine [42]. The 
monocarboxylate transporter (MCT), recently identified for the tea flavonoid 
ECG [43] was, actually, also included. MRP2, but probably also other MRP 
isoforms, has been demonstrated to be an important efflux transporter. This 
is most clearly the case for flavonoid glucuronide and sulfate conjugates [44]. 
Once absorbed, flavonoids and related phenolics follow the common 
metabolic pathway of exogenous organic substances and, like drugs and most 
xenobiotics, undergo phase II enzymatic metabolism. They can be conjugated 
with glucuronic acid, sulphate and methyl groups, in reactions catalysed by 
UDP-glucuronosyltransferases (UGTs), sulphotransferases (SULTs) and 
catechol-O-methyltransferases (COMT), respectively [45]. Phase II 
metabolism first occurs in the wall of the small intestine, after which 
metabolites pass through the portal vein to the liver, where they may undergo 
further conversions before entering the systemic circulation and eventually 
undergoing renal excretion. However, flavonoid metabolites are difficult to 
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quantify because only a few are commercially available as reference 
compounds and they are very complicated to synthesize [46].  
 
3. Mass spectrometry techniques for the characterization, 
identification and quantification of plant extract compounds 
3.1. MS analyzers and sources for biomolecules analysis 
Mass spectrometry has its origins around the beginning of the last century in 
the studies performed by J. J. Thomson [47] and F. W. Aston [48]. Today MS 
is the most sensitive method for the structural characterization of 
biomolecules. 
The introduction of the soft ionization methods, such as electrospray (ESI) [49] 
and matrix-assisted laser-desorption- ionization (MALDI) [50], led to several 
improvements in biochemical MS. While MALDI is the optimum method of 
ionizing peptides, ESI is the most efficient method for the ionization of polar 
biomolecules. Focusing on ESI-MS, this technique allows to analyze 
compounds in aqueous or aqueous/organic solutions, establishing it as a 
convenient mass detector for HPLC. In fact, ESI permits MS analysis at 
relatively high HPLC flow rates (1.0 mL/min) and high mass accuracy 
(±0.01%). 
In order to characterize and identify an unknown compounds the nominal 
mass is not enough when the compound of interest is in a complex matrix. 
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Thanks to the advent of high resolution mass spectrometer which possess 
high mass accuracy and high isotopic abundance accuracy, few molecular 
formula candidates can be obtained. Among the HR mass spectrometer there 
are time-of-flight (TOF), Fourier transform ion cyclotron resonance (FT ICR), 
and Orbitrap detectors. In addition to molecular weight, more details on the 
structure composition can be achieved by different type of fragmentation 
experiments. Fragmentation is usually performed by inducing ion/molecule 
collisions, process known as collision-induced dissociation (CID). As first one 
ion, called precursor, is selected by a mass analyzer and focused into a 
collision region preceding a second mass analyzer. In the collision region or 
cell product ions are generated and then detected by the second analyzer. 
These analyzers can be set in series either in space (triple quadrupole and 
hybrid instruments) or in time (ion trap instrument). Different MS/MS 
experiments, such as precursor ion scan, product ion scan, neutral loss scan 
and selected ion monitoring scan (Figure 2) [51], can be developed in order 
to reach the goal of interest (e.g. structure elucidation or quantitative analysis 
of selected ions in order to reach an higher selectivity and sensitivity). 
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3.2 Characterization, identification and quantification of plant extract 
compounds 
The analysis of polyphenols in the context of their natural source or in 
biological matrixes is a hard challenge and the analytical strategies depends 
on the sample and analytes characteristics. A chomatographic separation step 
before MS detection in always necessary for adequate analysis. Moreover, 
retention time can also give structural information. Since C18 or C8-RP 
columns are the most used in plant extract analysis, retention times are 
Figure 2 – Scan mode used in MS/MS analyses [51]. 
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inversely correlated with increasing glycosylation, whereas methylation has 
the opposite effect. The retention time is also influenced by the position of 
glycosylation [52] or methylation [53]. Frequently the flow deriving from the LC 
is splitted into two way, the first directed to the MS and the second to a UV 
diod-array detector. This choice is due to the known flavonoids characteristic 
UV absorption [54], which can provide adding information on the class of 
compounds. The MS analysis can be performed both in positive and negative 
ion mode. The negative ion mode shows the highest sensitivity [55], which is 
important where concentrations are low, while more structural information are 
obtained with the first-order mass spectrum in the positive ion mode contains 
more structural information [56]. Regarding the quantitative analysis, multiple-
reaction ion monitoring (MRM) methods are widely used because of the high 
selectivity obtained [57]. The amount of the analyte is determined by 
comparing the ratios of peak area of analytes to that of an internal standard.  
 
3.3 Sample preparation 
Sample preparation is a very important step in the analyses of complex 
matrices. Considering flavonoids in their original source homogenization, 
liquid extraction and filtration and/or centrifugation method can be adopted. 
The kind and amount of flavonoids isolated are subsceptible to the conditions 
use, such as temperature, pH and extraction solvent [58]. Sometimes further 
steps, such as purification or enrichment of some fractions, are necessary to 
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discard interference analytes. The method of choice in this case it is 
represented by solid-phase extraction (SPE) [59]. 
When flavonoids analysis is performed onto physiological fluids, such as urine 
and plasma, an initial extraction may be not necessary. However an 
hydrolyzation step can be considered by using β-glucuronidase, sulfatase, or 
a mixture containing both enzymes. After the hydrolysis the sample has to be 
extracted using liquid–liquid extraction or solid-phase extraction (SPE). In 
some cases protein removal is performed, e.g. on plasma samples, by solvent 
or acidic precipitation, followed by centrifugation and supernatant filtration. 
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